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ABSTRACT 
 Myosin IIIa, a motor protein that localizes to actin-rich regions f photoreceptors 
and to stereocilia of inner ear hair cells, is associated with the hearing process in 
vertebrates and with phototransduction for invertebrates.  It contains a large Pak-like 
kinase domain at its N-terminus that has previously been shown to autophosphorylate 
residue(s) on the motor domain.  We have characterized the autophosphorylation process 
and its influence on the motor’s ATPase activity and actin affinity using a phosphorylated 
version of our previously developed construct human MIIIa 2IQ, contrasting its activity 
with the kinase-dead MIIIa 2IQ K50R construct, which has a single substitution mutation 
in the kinase’s catalytic region. We have determined that autophosphorylation is an 
intermolecular process with rates ranging from ~0.05 min-1 to ~0.30 min-1 (0.01 - 1.2 µM 
MIIIa). Although proposed target autophosphorylation sites are near the motor’s actin 
binding region, the autophosphorylation rate is not affected by the presnce of actin 
filaments. We demonstrated that the MIIIa 2IQ ATPase rate in the presence of 20 µM 
actin decreases over time of pre-incubation with ATP (~40% in 1 h). The ATPase of fully 
phosphorylated MIIIa 2IQ has lower kcat and higher KATPase than unphosphorylated MIIIa 
2IQ or the K50R construct, while its steady-state actin affinity in the actin co-
sedimentation assay (KActin) is decreased.  
 We propose that phosphorylation of the myosin IIIa motor by its activated kinase 
domain reduces the molecule’s actin affinity.  This concentration-dependent 
autophosphorylation acts as a downregulatory mechanism that serves to main ain myosin 
IIIa/cargo concentration at actin bundle tips within physiologically determined limits for 
maintenance of stereocilia length and flexibility. This model is further supported by 
iv 
immunolocalization results (Kachar lab, NIH) in which a GFP-tagged version of the 
kinase-dead construct was demonstrated to localize more effectively to stereocilia tips 
than GFP-tagged wild type. 
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CHAPTER 1: REVIEW OF THE LITERATURE 
1.1 The Myosin Superfamily 
 The myosins are a superfamily of actin-based motor proteins whose individual 
members perform a wide variety of intracellular functions.  All myosins convert chemical 
energy to mechanical energy by hydrolyzing ATP in an actin-dependent manner.  
Coordination of the steps in their ATPase cycle with changes in both actin binding 
affinity and myosin conformation generates force (Sellers 1999), which typically results 
in translational movement of the myosin motor or of the associated acin filament (Figure 
1).  Examples of myosin-dependent processes include cellular contraction for cytokinesis 
or muscular activity, transport of organelles or molecular cargo along actin filament 
“tracks,” and generation of tension for cell motility or other specific cellular processes, 
including those that contribute to sensory functions. 
 
 All the myosins have at least three distinct domains:  a motor “head,” a lever arm 
“neck,” and a rod-like C-terminal tail (Figure 2).  The myosin motor is highly conserved, 
with both nucleotide binding and actin binding regions as well as numero s components 
Figure 1.  Scheme 1, which describes the actomyosin  ATP hydrolysis cycle. 
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that communicate between these two sites.  Relatively small structural variations in this 
domain for a particular myosin modify the motor’s biochemistry, matching its motor 
characteristics to the myosin’s cellular function (De La Cruz and Ostap 2004).  The neck 
domain is called the 
lever arm because it 
pivots during the 
ATPase cycle in order 
to amplify head movements and magnify force against an actin filament during the 
hydrolysis cycle.  The lever arm’s stability is enhanced by the binding of calmodulin or a 
calmodulin-like light chain at each of its IQ motifs, which range in number from one to 
six among the known myosins. The myosin tail is its most divergent domain, reflecting 
the molecule’s cellular function according to the specific binding partner(s) with which 
the particular myosin isoform associates. Examples include vesicular or molecular cargo, 
membrane components, or filament-forming tail regions of adjacent myosin molecules.   
 There is some variation in the way the myosin superfamily is subdivided, but 
currently its members are reported to comprise either 24 classes (Foth et al 2006) or 35 
classes (Odronitz and Kollmar 2007), each including numerous subclasses and isoforms. 
All eukaryotic species require at least two distinct myosin types and most have nine or 
more, though no specific class is common to all species (Richards and Cavalier-Smith 
2005).  Eleven classes have been found in the vertebrates (Foth et al 2006). The first 
identified and most familiar representatives of the myosin superfamily are the muscle 
myosins, all of which dimerize and assemble into contractile elements called thick 
filaments.  These thick filaments interact with actin-based thin filaments within highly-
             Motor                   Neck               Tail    
 
-C 
 
N-
-- 
Figure 2.  Generalized myosin structure. 
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ordered contracting structures known as sarcomeres.  The filament-forming myosins, 
both muscle and non-muscle types, make up class II and are known as the “conventional” 
myosins.  The 
remaining classes, 
the unconventional 
myosins, function as 
either monomers 
(myosins I and III, 
for example) or as 
dimers (myosins V 
and VI) that move 
unidirectionally on 
actin filaments, all 
with the exception 
of myosin VI 
toward the “plus” end.  Inactive myosin molecules generally dissociate from the actin 
filament in the presence of ATP and become free to diffuse unless tethered in place by 
tail binding. Figure 3 shows an unrooted phylogenetic tree illustrating the relationships 
among the myosin classes and subclasses based on distance matrix analysis (Clustal-W) 
using the chicken muscle myosin motor for reference (Dosé et al 2003). 
1.2 Class III Myosins 
 
 
 Myosin III was the third myosin class to be identified (Montell and Rubin 1988).  
It was initially identified from its expression in photoreceptors and in the inner ear 
Figure 3.  Unrooted phyloge netic tree of myosins, from The Myosin  
Home Page (Hodge and Cope 2000 ). 
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sensory cells (hair cells), where it associates with bundled actin.  Myosin III was 
identified as the gene product of the ninaC gene in Drosophila melanogaster, so named 
because of the observation that its deletion results in neither inactivation nor activation of 
the photoreceptor response (Montell and Rubin 1988).  Since then, representatives of the 
class III myosins have been identified in both invertebrates and vertebrates.  The 
properties of myosin III isoforms from several species in addition to Drosophila 
melanogaster have 
been investigated, 
most notably from 
Limulus polyphemus 
(horseshoe crab), Morone saxatilis (striped bass), Mus musculus (mouse) and Homo 
sapiens (human).  In all known cases except Limulus two myosin III isoforms are present, 
with the longer one designated myosin IIIa (p174 in Drosophila) and the shorter myosin 
IIIb (for Drosophila, p132); Limulus expresses only the longer isoform. The two isoforms 
are encoded by separate genes except in Drosophila where they are splice variants of a 
single gene (Montell and Rubin 1988). 
 The class III myosins have unique structural features that distinguish them from 
other members of the myosin superfamily (Figures 4 and 5). Most notable among these is 
their N-terminal kinase domain that has been shown to be able to phosphorylate other 
proteins as well as autophosphorylating the myosin III motor (Ng et al 1996, Komaba et 
al 2003).  The myosin IIIa motor is relatively divergent, with approximately 25% 
homology to the class I and class II myosin motors (Cheney t al 1993).  Our lab has 
reported the characteristics of the human myosin III motor to include slow steady-state 
 Figure 4 .  Schematic diagram of myosin IIIa structure.  
IQ1,2            IQ3    3THD1       3THDII  
    Kinase         Motor           Neck         Tail            
N- -C 
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ATPase activity with high actin concentrations required for full activation, and rate-
limiting ADP release as is typical for a high duty ratio motor (Dosé et al 2006). Its lever 
arm has two IQ motifs that bind calmodulin, and its tail includes a third IQ motif and a 
tail homology domain I (3THD1) 
that has recently been reported to 
bind the SH2 domain of the actin 
bundling protein espin 1, 
transporting this protein to actin 
filament tips and thereby 
contributing to stereocilia elongation 
(Dosé et al 2003, Salles et al 2009).  
The number of IQ motifs in the neck 
and the tail is quite variable, and both fish and Limulus class III myosins have more than 
the human isoforms (Dosé et al 2003). Human myosin IIIa but not IIIb also has a tail 
homology domain II (3THDII) that includes an actin binding motif proposed to 
contribute to processive movement along actin filaments.  Neither isoform appears to 
have a sufficient coiled coil-forming region to dimerize, so it is most likely a one-headed 
myosin (Dosé et al 2003).  There is greater sequence homology among the known 
myosin IIIa isoforms of different vertebrate species than between the IIIa and IIIb 
sequences within the same species (Katti et al 2009).  
 Class III myosins appear to be exclusive to photoreceptors in Drosophila and 
Limulus, and are also highly expressed in vertebrate retinal tissues and inner ear sensory 
receptor cells.  Vertebrate myosin III transcripts are detectable in brain, kidney, testes, 
Figure 5.  Ribbon diagram of proposed 
structure of myosin III kinase, motor and lever 
arm domains. 
Kinase 
Motor 
Domain 
Regulatory Domain/ IQ 
Motifs 
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intestine and pancreatic tissue as well. However, for both bass myosin IIIa and IIIb,  
transcription levels are reported to be considerably lower in the on-sensory tissues (ten 
to fifty times lower for myosin IIIa, two to four times lower for IIIb) (Dosé et al 2000, 
Dosé et al 2003). Specific functions for class III myosins in non-sensory tissues are ayet
undetermined (Dosé et al 2000, Dosé et al 2003, Katti et al 2009). In fish, both myosin 
III isoforms are present at the photoreceptors but only MIIIa transcript expression has 
been detected in the cochlea (Dosé et al 2003, Walsh et al 2002). The consensus of 
numerous studies over more than a decade is that class III myosins play important roles 
in several aspects of hearing and vision, but there is much that remains to be determined. 
1.3 Myosin IIIa and Vision 
 
 The visual process has been extensively investigated in Drosophila 
photoreceptors, which have the fastest G protein-coupled signaling cascade yet identified.   
Both vertebrate and invertebrate photoreceptors are highly polarized cells with a cell 
body and a signaling compartment called either 
the outer segment (vertebrate) or the 
rhabdomere (invertebrate) (Figures 6 and 7). 
The signaling compartment houses the major 
proteins essential for phototransduction and 
either contains stacked membranous discs 
(vertebrates) or has thousands of microvilli in a 
comb-like arrangement down one side 
(invertebrates).  In this compartment photon 
Rhabdomere/ 
microvilli
Rhabdomeres
Cell 
body
Figure 6.  A single invertebrate 
photoreceptor cell with its rhabdomere, 
left.  At right is a transverse section of one 
ommatidia, showing the orientation of 
rhabdomeres. 
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absorption by the photopigment rhodopsin activates a G protein (Gqα for Drosophila, 
transducin for vertebrates) to initiate a sequence of events that results in activation 
(deactivation in the vertebrate system) of the light sensitive ion channels TRP and TRPL. 
Reversal of the response involves inactivation of the photopigment by its inding with 
arrestin2 and interaction with Ca++.   
 It has been established that several of these key signaling proteins undergo light-
dependent translocations into and out of the signaling compartment, a shuttling that 
appears to be essential for adjusting both sensitivity and speed of thephotoresponse. 
Altering the concentration of signaling proteins is an adaptive response to the broad range 
of light intensities within which photoreceptors function. The Gα and β subunits and 
TRPL cation channels are concentrated in the signaling compartment in dark-adapted 
animals but approximately fifty percent of each of these 
proteins shuttles to the inner segment/cell body over the 
course of several minutes of light exposure.  Visual 
arrestin1 and arrestin2 translocate in the opposite direction 
upon light exposure, from the cell body or inner segment 
into the outer segment/rhabdomere where they participate 
in response termination. 
 In both vertebrate and invertebrate photoreceptors 
myosin III is heavily associated with areas rich in bundled 
actin filaments (Diagrams 6 and 7), particularly between 
the cell body/inner segment and the rhabdomere/outer segment.  This region’s bundled 
actin filaments are directionally organized so that their plus ends are oriented either 
Outer 
segment
Inner 
segment
Cell body
Connecting cilium 
with calycal
processes
Synaptic 
ending
Figure 7.  Vertebrate 
photoreceptor (rod). 
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toward the signaling compartment or, for vertebrates, are contained within microvilli-like 
structures called calycal processes that project from the bas of the outer segment of 
vertebrate photoreceptors.  Their minus ends extend into the cell body/inner segment 
(vertebrates) or even beyond into the myoid region (Nagle et al 1986).  Null mutants of 
the ninaC gene products undergo light-induced degeneration of the retina and disruption 
of the actin cytoskeleton, which suggest that these gene products are needed for cell 
maintenance (Matsumoto et al 1987). The Drosophila isoforms are differentially 
localized, with p174 contained within the rhabdomeres and p132 in the cell bodies of 
photoreceptors (Porter t al 2002).  Fish myosin IIIa is heavily concentrated at the tips of 
calycal processes and is also present in the actin-rich regions of the inner segment, while 
myosin IIIb has been visualized as having a more generalizd distribution in these 
regions as well as the outer segment (Dosé et al 2003, Lin-Jones et al 2009).  
Immunolocalization studies revealed that fish myosin IIIa is abundant in the retinal 
pigmented epithelium, while IIIb was detected in the retina’s outer limiting membrane, 
which is formed by actin-containing projections from the glial Müller cells (Lin-Jones et 
al 2009). A similar differential distribution has very recently been r ported for mouse 
myosin IIIa and IIIb (Katti et al 2009).  
1.4 Roles of Class III Myosins at Invertebrate Photoreceptors  
 
 
 Several lines of evidence have implicated both of the Drosophila ninaC gene 
products (myosin III isoforms p174 and p132) in the visual process.  The p174 isoform is 
essential for response termination (Porter e  al 1992), and while both isoforms influence 
long-term adaptation to changes in light intensity, p132 in particular is needed for a 
normal response (Lee and Montell 2004).  Arrestin is the photoreceptor protein that 
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initiates termination of the light signal by binding to photoexcited and phosphorylated 
rhodopsin. Arrestin translocates from the cell body into the rhabdomere as light exposure 
excites increasing quantities of rhodopsin, consequently requiring more and more arrestin 
for adequate quenching (Peet et al 2004).  The light-dependent translocation of visual 
arrestin2 was shown to be based on the binding of Arr2 to phosphoinositide (PIP3)-
enriched vesicles, and evidence has been presented implicating myosin IIIp132 as the 
Arr2 transporter via a tail linkage to (PIP3)-enriched vesicles (Lee and Montell 2004).  
However, this requirement for NINAC has been more recently challenged by Satoh and 
Ready (2005), who did not find a NINAC (myosin III) requirement for translocation of 
either arrestin1 or arrestin2 (Satoh and Ready 2005). The light-dependent process is 
complete within ten minutes, while the retrograde movement of Arr2 that reestablishes 
resting conditions requires several hours and has been attributed to diffusion rather than 
myosin motor activity (Lee and Montell 2004).  
 A light-instigated shift of much of the Gqα from the Drosophila rhabdomere to the 
cell body takes place within five minutes of continuous illumination and is dependent on 
light intensity, while in darkness the translocated Gqα returns to the rhabdomeres.  These 
compartment shifts are essential for long-term adaptation to light intensity. Gqα’s rapid 
exit from rhabdomeres is dependent on rhodopsin activation by light but does not require 
NINAC protein nor any of the downstream signaling components investigated (Cronin et 
al 2004) and is independent of arrestin or TRPL channel movements (Cronin et al 2004). 
However, Gqα’s normal rate of return to the rhabdomeres does appear to involve myosin 
III,  yet because it will slowly take place even in the absence of myosin III it may be that 
diffusion plays a role as well (Cronin et al 2004).  The authors point out that because 
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myosin III is both a motor protein and a functional kinase, it is possible that Gqα transport 
may depend upon its kinase activity rather than motor function (Cronin et al 2004). 
While vertebrate myosin III has been demonstrated to exhibit motor activity in the in 
vitro sliding assay (Komaba et al 2003), and movement into the rhabdomere is in the 
expected direction for a plus-end directed motor, there has not yet been dir ct verification 
of mechanoenzymatic activity for the invertebrate myosin IIIs.  It has been suggested that 
the lack of a critical salt bridge in the invertebrate motor may prevent motor activity, and 
that myosin III’s function in Limulus may be as an actin binding protein (Kempler et al 
2007).   
 Drosophila myosin III is capable of concentrating calmodulin (CaM) in the 
rhabdomere, which it can bind not only by lever arm IQ motifs but also by its multiple 
tail domain IQ motifs (Porter and Montell 1993). It has been proposed that calmodulin 
transport gives p172 an indirect role in Ca++ dependent metarhodopsin inactivation, 
essential to the termination of the light response. Calmodulin may act as an intermediate 
that responds to calcium influx by accelerating the rate of arrestin binding to 
metarhodopsin (Liu et al 2008).  Recent studies indicated that the Ca++ dependence did 
not depend on rhodopsin dephosphorylation when normal calmodulin was present, but 
when Ca++ was present rhodopsin could not be inactivated in the presence of mutant 
calmodulin nor of NINAC mutants (Liu et al 2008). The authors suggest a mechanism 
whereby CaM and NINAC mediate localized Ca++ influx in the rhabdomere, which 
accelerates the binding of arrestin to activated metarhodopsin and is said to promote high 
efficiency, temporal resolution and fidelity of the signaling process (Liu et al 2008). 
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 Studies investigating the light-induced translocation of TRPL channels from 
rhabdomere to cell body have revealed that this is dependent on calcium influx through 
the Ca++ specific TRP gated channels, and is an important component of reduced 
photosensitivity under bright light conditions.  Activation of very low (<1%) levels of 
rhodopsin and Gqα trigger the translocation (Liu et al 2008).  A NINAC mutant showed 
partially compromised TRPL-eGFP rhabdomeric recovery in the dark, but this has been 
attributed to secondary effects of the mutation, particularly its disrupted actin 
cytoskeleton and retinal degeneration (Meyer et al 2006, Matsumoto et al 1987). Because 
TRPL is a transmembrane protein it cannot be solubilized and thus its translocation is 
expected to require an endocytotic pathway (Meyers et al 2006). 
 The signalplex, a large assembly of many of the proteins critical for Drosophila 
phototransduction (TRP channels, rhodopsin, phospholipase C, protein kinase C, and G 
protein coupled receptors), localizes to the rhabdomere and is assembled by the PDZ-
domain scaffolding protein INAD (Wes et al 1999). It was demonstrated that INAD binds 
directly to NINAC, and disruption of the interaction slows the termination of the 
photoresponse although it does not affect NINAC localization (Wes et al 1999). The role 
played by myosin III as a component of the signalplex remains to be determined. 
 The Limulus myosin III in lateral compound eyes localizes to rhabdomeres, where 
it undergoes phosphorylation changes in concert with circadian rhythms (Edwards and 
Battelle 1987; Cardasis et al 2007).  There are numerous structural and functional 
changes that take place in these photoreceptors in association with the light-dark cycle, 
and myosin III phosphorylation status may mediate some of these changes (Kempler et al 
2007). Phosphorylation of certain target residues may influence actin affinity, and it is 
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suggested that changes in phosphorylation status may “prime” the la eral eye 
photoreceptor to undergo transient membrane shedding from the microvilli of the 
rhabdomere (Cardasis et al 2007). 
1.5 Roles of Class III Myosins in Vertebrate Vision 
 
 
 The functional processes of vertebrate photoreceptors are similar in a general way 
to invertebrates.  Rhodopsin is activated by light, activating the G protein subunit 
transducin α which induces the photoresponse, which is accomplished by stimulating 
cGMP phosphodiesterase to rapidly reduce intracellular cGMP and close the gated cation 
channel in the plasma membrane. The events of rapid recovery from the photoresponse 
are also similar, involving phosphorylation of photoexcited rhodopsin and subsequent 
arrestin binding, with regulation of rhodopsin kinase activity by a calcium binding 
protein.  As described for invertebrates, key vertebrate signaling proteins also undergo 
massive intracellular translocation for adaptation.  Calvert et al (2006) estimated the rates 
of diffusive equilibrium in the outer segment, inner segment and connecti g cilium of 
rods, and concluded that diffusion may successfully explain the light-initiated 
translocation of both transducin and arrestin without assistance from a motor bound 
transport. Currently the dark adaptation mechanism for returning transduci  and/or 
arrestin to their inactive concentrations in each compartment is not well enough 
understood to allow potential roles to be distinguished between molecular motors and/or 
diffusion in these processes (Calvert t al 2006). Fish myosin IIIa transgenic expression 
in Xenopus laevis rod photoreceptors resulted in abnormally large actin filament bundles 
in the calycal processes, which was interpreted as suggestive of a role for myosin IIIa in 
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the morphogenesis and maintenance of actin bundles, perhaps in addition to other 
functions related to cytoplasmic transport and/or signaling (Lin-Jones et al 2004).      
1.6 Myosin IIIA and Human Hearing 
 
 
 A naturally occurring set of three mutations in the human myosin IIIa gene has 
been designated as the nonsyndromic progressive recessive form of deafness DFNB30, 
which has no known corresponding visual or balance defect (Walsh et al, 2002).  
DFNB30 was described in three generations of an Israeli family of Iraqi descent, who 
experience bilateral hearing loss that progresses from reduced high-frequency hearing in 
the second decade to severe hearing loss by age fifty (Walsh et al, 2002). Three 
mutations within the myosin IIIa gene were identified in the aff cted family members. 
The earliest age of onset along with significantly poorer hearing during the progressive 
stages were associated with homozygosity of a nonsense mutation, a single substitution in 
exon 28 in codon 1043 (3126T→G) resulting in a premature stop codon that truncates the 
protein at its head/neck junction (Walsh et al, 2002).  The other two mutations were 
localized to the splice acceptor sites of intron 17 and intron 8, one resulting in deletion of 
exon 18 in the motor domain and the other producing an unstable message so that
expression is significantly reduced (Walsh et al, 2002). All homozygotes for any of these 
mutations eventually developed deafness of equal severity by the sixt  decade, while 
simple heterozygotes were unaffected (Walsh et al, 2002). This investigation within a 
single family demonstrated that myosin IIIa is required for normal hearing and suggested 
that other mutations in this gene may also exist, perhaps some that affect both vision and 
hearing as reported for myosin VIIa in the disease Usher 1b (Walsh et al, 2002; Petit et 
al, 2001 review). 
 14 
 The discovery of DFNB30 has resulted in the recent myosin IIIa resea ch focus 
on its role in the inner ear sensory receptor cells (Figure 8).  It has been shown to 
associate with the actin bundle cores of stereocilia, the highly specialized microvilli on 
the apical surface of inner ear hair cells that contain mechanoresponsive cation channels. 
Myosin IIIa localizes to the tips of filopodia in HeLa and COS-7 cells (Dosé et al 2007; 
Salles et al 2009), and the same GFP-tagged construct has been found to localize to a 
previously unidentified compartment at the tips of stereocilia on inner ear hair cells 
(Schneider et al 2007). It was recently shown to colocalize with the actin bundling 
protein espin I at stereocilia tips, 
and the combined overexpression 
of both myosin IIIa and espin I 
resulted in more stereocilia 
elongation than over expression of 
either alone, an effect that was 
even more pronounced in filopodia 
of COS-7 cells (Salles et al 2009). 
 The sensory tissues of the 
auditory epithelium are said to be “the most precisely and minutely engineered tissues of 
the body” (Alberts et al 2002). The hair cells of this epithelium have elongated 
mechanosensory protrusions on their apical surfaces called stereocilia, which are 
organized precisely into staircased rows, with each one attached to the adjacent taller one 
by a fibrous tip link (Figure 9).  These cells respond to auditory stimuli by triggering a 
receptor potential called the MET (mechanoelectrical transduction) current when their 
Figure 8 .  Cochlea cross section showing the 
position and appearance of rows of outer and 
inner hair cells in organ of Corti. (Encyclopedia 
Britannica, 1997) 
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stereocilia are perturbed by endolymph fluid vibrations.  Not only are stereocilia lengths 
regulated according to row on an individual hair 
cell, but also there is a gradual decrease in length 
around the two and a half turns of the cochlea from 
its base to its apex, sensitizing different regions of 
the organ of Corti to vibrations of different 
frequencies. Stereocilia are highly specialized 
microvilli and so have bundled parallel actin 
filaments at their core, with the plus ends of the 
filaments oriented toward the tip.  These bundles 
are continually renewed by a treadmilling process in 
which they add new actin monomers as well as 
actin bundling proteins at their tips and remove “old” ones from their base, and yet 
continuously maintain their precise lengths and functionality.  Not surpri ingly stereocilia 
have numerous myosin isoforms in association with them.  At least six of these, including 
myosin IIIa, are known to be essential to the hearing process, either directly during 
response to a stimulus or indirectly as a component of maintenance or r gulatory 
processes, and have been demonstrated to be associated with specific hearing disorders 
when mutated (Redowicz 2002 review, Friedman et al 2007 review). (see Figure 9). Each 
stereocilium’s length, flexibility, and intracellular and transmembrane components must 
be carefully regulated and maintained for a lifetime in order for these terminally 
differentiated cells to remain functional. Elucidating the role played by specific myosins 
Figure 9.  Stereocilia with 
representative associated 
myosins, MET complex and tip 
links. (Schneider et al, 2006) 
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is essential to understanding the hearing process at the molecular l vel, as well as for the 
eventual development of treatments to reverse myosin-related hearing defects. 
 Developmentally, the appearance of detectable levels of myosin IIIa stereocilia 
is associated with the maturation of actin bundle structure and also coincides with or 
closely precedes the onset of MET currents (Waguespack et al 2007), suggesting a role in 
transporting components either of the MET machinery or of the stereociliary structure.  
Myosin IIIa encloses the tip of the actin bundle in a thimble-like pattern, distinct from the 
distribution pattern of other myosins of the stereocilia (Schneider et al 2006).  
Localization requires the motor domain but not the actin-binding motif of the tail 3THDII 
domain, and deletion of the kinase domain results in both stereocilia elongation and 
bulging of the tip compartment occupied by myosin IIIa (Schneider et al 2006). This 
compartment encompasses both the region of the MET machinery and the site of actin 
polymerization, suggesting that myosin IIIa may participate in either or both of these 
processes.  Similar colocalization of myosin IIIa and the actin bundling protein espin 1 
was observed.  Overexpression of either of these two proteins is associated with 
stereocilia elongation, while overexpression of both causes greater elongation (S lles et al 
2009).  The myosin IIIa 3THD1 domain associates with the WH-2 motif of espin 1 
(Salles et al 2009).  These results indicate that at least one function for myosin IIIa s the 
transport of espin 1 to stereocilia tips, but do not preclude the possibility of other roles as 
well, perhaps transport of MET components in an analogous function to what has been 
observed in Drosophila photoreceptors (Salles et al 2009). 
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1.7 Potential Partial Overlap in Myosin IIIA and IIIB Function 
 
 
 While discovery of the human myosin IIIa mutations that are causative for the 
DFNB30 deafness phenotype has spurred investigations to elucidate its role in the 
hearing process, it also raises questions about the lack of a visualcomponent in this 
disease, especially given myosin IIIa’s importance for Drosophila vision. It has been 
hypothesized that a redundancy of function exists in vertebrate photoreceptors, so that 
perhaps the similarities between myosin IIIa and myosin IIIb structure, in conjunction 
with their overlap in localization and function may provide an explanatio . Two recently 
published reports describe localization studies for myosin isoforms in the eye, one in fish 
and the other in mice (Lin-Jones t al 2009; Katti et al 2009). Both show partial overlap 
of myosin IIIa and myosin IIIb localization, most notably at the actin-rich distal portion 
of the inner segment (Lin-Jones t al 2009; Katti et al 2009).  Further studies are required 
to confirm whether this localization overlap actually translates to a redundancy of 
function sufficient to overcome the myosin IIIa deficiency associated with DFNB30.  
1.8 Regulation of Myosin IIIA Motor Activity 
 
 
 The regulation of myosin motor activity is crucial to its cellular functionality, and 
any explanation of the myosin’s cellular role is incomplete without a determination of  
how it is regulated.  In order for myosin IIIa to be able to maintain proper stereocilia 
lengths it must transport the necessary amount of espin I to be incorporated at their actin 
bundle tips.  A kinase-deleted construct developed in our lab (MIIIa 2IQ ∆K) has been 
demonstrated to have a higher maximum rate of ATPase activity and stronger actin 
affinity than the comparable construct containing the kinase domain (MIIIa 2IQ) (Dosé et 
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al 2006, Dosé et al 2008).  Compared to MIIIa 2IQ, it localizes more effectively to actin 
bundle tips in filopodia and stereocilia while simultaneously elongating them (Dosé et al, 
2006; Salles et al 2009). This suggests that the myosin IIIa kinase domain is involved in 
downregulation of function by influencing the activity of its motor. 
 Mechanisms for regulating myosin activity to maintain proper cellular f nctioning 
have not yet been elucidated for many of the unconventional members of the myosin 
superfamily, but phosphorylation and dephosphorylation are among known myosin 
regulatory processes that also include calcium binding and availability of cargo.  For the 
conventional myosins, calcium’s role in the tight regulation of motor activity has been 
investigated extensively.  The stimulus for contraction in cardiac and skeletal muscle 
results in sudden calcium influx in the vicinity of the contractile apparatus, calcium 
binding to the thin (actin/troponin/tropomyosin) filament and subsequent induction of a 
structural change that allows actomyosin cycling to begin (Huxley 1971, Vibert et al 
1997).  For smooth muscle myosin and the non-muscle class II myosins, calcium influx 
results in myosin light chain kinase (MLCK) activation, phosphorylation of the myosin 
regulatory light chain by activated MLCK and subsequent motor conformational change 
to an active state (Trybus et al 1994).  Cessation of the stimulus prevents further activity 
by various means involving dephosphorylation of the light chain, calcium removal, and 
motor/tail phosphorylation (Trybus et al 1994).  
 Much less is known about regulation of unconventional myosin activity, but it 
appears to be accomplished by several means.  Myosin V motor regulation has been 
reported to involve calcium concentration influences on both calmodulin light chain 
binding and tail-motor interactions (Krementsov et al 2004, Lu et al 2006) as well as 
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cargo binding to the globular tail domain (Olivares et al 2006).  The calcium dependent 
structural changes are characterized by an extended, active conformation and a 
conformation that is inactive and folded, in which the myosin V globular tail domain 
blocks the motor’s active site (Krementsov et al 2004). Tail-motor interactions may 
regulate myosin VII activity as well (Umeki et al 2009). For many myosin I isoforms, 
motor phosphorylation of a serine or threonine residue at the highly conserved TEDS site 
(the amino acid residue must be a phosphorylatable threonine or serine, or an acidic 
glutamic or aspartic acid) on a surface loop of the actin binding region has been shown to 
upregulate motor activity (Bement and Mooseker 1995 review; Brzeska and Korn 1996; 
Redowicz 2001 review).  In myosin VI the role of phosphorylation at the TEDS site’s 
threonine residue is less clear, but in addition to calcium concentratio  it may influence 
the motor’s kinetic properties (De La Cruz et al 2001; Morris et al 2003; reviewed in 
Buss and Kendrick-Jones 2009).   
 Motor phosphorylation of human myosin IIIa is not at the TEDS site but rather 
has been determined by limited chymotrypsin proteolysis to be within a 20 kDa peptide at 
the C-terminal end of the motor (Komaba et al, 2003). Recent studies of Limulus myosin 
IIIa, which is found in photoreceptors of lateral eyes where its phosphorylation is 
associated with increased retinal sensitivity at night, indicate that autophosphorylation of 
this myosin takes place at several sites within and near loop 2, an important actin binding 
region that partially overlaps with the 20 kDa peptide region identifi d by Komaba 
(Kempler et al 2007).  Studies involving selective point mutations in the loop 2 sequence 
have revealed that, for myosin II motors, loop 2 influences both actin affinity and 
phosphate release (Uyeda et al, 1994; Murphy and Spudich, 1999), while in myosin V it 
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apparently is important for allowing actin binding during the relatively weak binding 
states (Yengo and Sweeney 2005).  Actin affinity has been found to increase with 
increasing loop 2 net positive charge (Joel et al 2003), so the charge reduction associated 
with loop 2 phosphorylation may be expected to decrease actin affinity. 
1.9 Characteristics of  the Myosin IIIA Kinase 
 
 
 The myosin III kinase has greatest sequence homology to the catalyti  region of 
the p21 activated kinases, specifically the Pak1 and Ste20 kinase groups (Sells and 
Chernoff 1997; Dosé et al 2003).  This family of serine-threonine kinases includes those 
that phosphorylate the TEDS sites of amoeboid myosin I and myosin VI for activation 
and those that are important in regulating polymerization of the actin cytoskeleton 
(Daniels and Bokoch 1999).  The Pak kinases are themselves regulated by 
phosphorylation, with a highly conserved activation target residue in the ca alytic site. 
Although most also include a phosphorylatable regulatory domain, the myosin IIIa kinase 
does not (Parrini et al. 2002).  
 Pak kinases are “basophilic kinases” in that they preferentially phosphorylate 
substrates that have basic residues near the phosphorylation site, due to interactions with 
two acidic residues that create a negatively-charged pocket in thekinase’s major groove. 
(Ghu et al 2005). Each basophilic kinase family appears to prefer basic residues in a 
different set of positions around the target serine or threonine (Ghu et al 2005). The Pak1 
kinases are distinguished by an exceptionally strong preference for arginine in the target 
residue’s “P -2” position. They also share a strong preferenc for arginine at “P -5,” and 
also favor arginine at “P -3” and “P -4,” (negative number indicates th  position of the 
basic residue upstream (N-terminal) from the phosphorylation target) (Zhu et al 2005, 
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Rennefahrt et al 2007).  Specificity profiling of selected Pak1 kinases was used to 
develop position specific scoring matrices (PSSM) of neighboring residues around known 
phosphorylation targets, and substrate specificity was found to be virtually 
indistinguishable among the kinases of the Pak1 family (Rennefahrt et al 2007).  It is 
suggested that this research group’s Pak PSSM along with the Internet-based Scansite 
tool can be used as a mechanism for prioritizing direct testing of potential target residues 
in a putative substrate (Rennefahrt et al 2007). This technique may be useful in the 
process of identifying specific autophosphorylatable target threonines a d/or serines in 
the myosin IIIa molecule. 
 Based on the current understanding of myosin IIIa function in inner ear hair cells, 
it is evident that myosin regulatory activity is necessary in order to maintain stereocilia at 
the appropriate length with proper bundling of their actin core.  It has been demonstrated 
that the myosin IIIa cargo, the actin bundling protein espin I, is incorporated into the 
actin bundle solely at its tip, which contains the plus ends of its component parallel 
filaments (Salles et al 2009).  Excessively long stereocilia and filopodia have resulted 
from transfection of either exogenous myosin IIIa or espin I, ad markedly so when the 
two proteins were cotransfected, while stereocilia were short and non-functional when 
espin I was lacking (Schneider t al 2006, Salles et al 2009, Zheng L et al 2000.; 
Rzadzinska et al 2002).  Transfection of kinase-deleted myosin IIIa or to a lesser ext nt, 
kinase-dead, results in its increased accumulation at actin bundle tips along with 
elongation and reduced rigidity of the actin bundle (Dosé et al 2006, Schneider et al 
2006, Salles et al 2009).  
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1.11 Hypothesis  
 
 
 These studies provide support for a general hypothesis that myosin IIIa motor 
activity may be down-regulated by autophosphorylation in a manner consistent with a 
negative feedback mechanism.  This regulatory mechanism would allow the myosin IIIa - 
espin I system to maintain each stereocilium at the length appropriate for its proper 
response to fluid vibrations of its targeted frequency and magnitude.  We propose that the 
dual kinase-motor structure of myosin III and the preference of the kinase domain to 
autophosphorylate the motor in an intermolecular manner provide a mechanism for self-
regulation of myosin III concentration as it accumulates at the ips of actin bundles.  The 
bulging stereocilia or filopodia tips characteristic of cells transfected with kinase-deleted 
MIIIa-GFP suggest that myosin molecules travel to the plus ends of the actin filament 
bundle and remain attached upon arrival in the tip compartment, lacking a mechanism for 
turning the motor off and/or for reducing their actin affinity. The kinase deleted 
construct’s high steady-state ATPase rate and high actin affinity relative to wild type also 
support the concept that this is an unregulated motor. The kinase-dead constru t, which 
has only a single substitution mutation rendering it unable to autophosphorylate its motor, 
also accumulates at actin bundle tips and elongates filopodia beyond the levels observed 
for wild type transfections.  We suggest that this accumulation is due to the lack of a 
down-regulatory effect on the motor from autophosphorylation, and that maintenance of 
actin bundle lengths is dependent upon the concentration of myosin IIIa in the tip 
compartment. The differences observed between kinase-dead and kinase-deleted myosin 
IIIa may be attributable to structural interactions between the kinase and the mo or.  
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 Specifically we hypothesized that the autophosphorylation processes responsible 
for both activating the kinase domain and phosphorylating the motor domain of myosin 
IIIa are concentration dependent and can take place in the presence of a tin filaments. 
Further, when the kinase domain is active it is capable of autophosphorylating the motor 
domain in the loop 2 region by an intermolecular process, thereby reducing the motor’s 
activity and actin affinity.  We tested this hypothesis by monitoring the rate of 
autophosphorylation across a series of myosin concentrations and in the presence as 
compared to the absence of actin filaments.  Furthermore, we measured the steady state 
enzymatic activity and actin affinity of a fully-phosphorylated myosin IIIa, in comparison 
to both an unphosphorylated control and a kinase dead myosin IIIa construct. We report 
herein results that show phosphorylation to reduce the activity of the myosin IIIa motor 
and to reduce its actin affinity.  In addition, the lack of motor phosphorylation is 
associated with higher actin affinity. We also report findings that indicate 
autophosphorylation rates are directly proportional to myosin concentratio , consistent 
with autophosphorylation as an intermolecular process.  Our results suggest that levels of 
phosphorylated myosin are adjusted according to the concentration of myosin present.   
 Because the negative charge associated with phosphorylation of target residues in 
critical regions of the motor has the potential to reduce actin aff ity and/or rate of 
product release, autophosphorylation may serve to down regulate myosin IIIa motor 
activity.  Our comparison of phosphorylated and unphosphorylated myosin IIIa 
constructs in steady-state ATPase and actin binding assays provide further s ppo t for our 
model of myosin IIIa down-regulation of motor activity by autophosphorylation as a 
mechanism for maintenance of actin bundles in stereocilia.  We show in vitro evidence 
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that autophosphorylation is not hindered by the presence of actin filaments, so it is 
reasonable to suppose that the myosin motor can be phosphorylated in vivo as well. This 
work contributes to our overall understanding of maintenance of the hearing response at a 
fundamental level.  As structural, biochemical, and cell biological roles of the various 
myosins and other proteins essential to the visual and auditory processes are elucidated 
the groundwork will be laid for a better understanding of how disruptions in their genes 
contribute to sensory disorders.  Knowledge of the role of myosins in sensory cells 
interactions may serve as a basis for future development of treatments for visual and 
hearing-related disorders. 
 
 
CHAPTER 2: INTRODUCTION 
 Myosin IIIa, an unconventional myosin localized to the calycal processes of 
photoreceptors and the stereocilia of the inner ear, is unique among members of the 
myosin superfamily in that its structure includes an N-terminal domain with serine-
threonine kinase activity (Dosé and Burnside, 2000; Komaba et al, 2003).  This domain is 
similar to the catalytic domain of the Pak1 kinases and is capable of autophosphorylating 
site(s) at the C-terminal end of the myosin IIIa motor domain (Komaba et al, 2003).  The 
lever arm of myosin IIIa contains two isoleucine-glutamine rich IQ motifs which bind 
calmodulin or myosin light chains.  Typically the structure of the tail region for a specific 
class and subclass of myosin reflects its unique role in the cell, and in myosin IIIa it 
includes a third IQ motif, the myosin tail homology 1 motif (3THDI), and the tail 
homology II actin-binding motif (3THDII) near its C-terminus.  Because there is no 
evidence of a coiled-coil forming region myosin IIIa is presumed to be a single-headed 
myosin. Human myosin IIIa has demonstrated both ATPase activity and the ability to 
move actin filaments in vitro, consistent with the characteristics of a cellular transporter 
or force transducer (Komaba et al, 2003; Dosé et al, 2007; Kambara et al, 2006; Dosé et 
al, 2008). 
Myosins couple ATP hydrolysis with changes in both conformation and actin
binding affinity in order to cyclically generate mechanical force along actin filaments. 
Small differences among myosin motor domains result in properties fin ly-tuned for a 
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specific myosin’s biological role in the cell (Holmes and Geeves, 1999).  Additionally, 
motor function may be regulated intracellularly by variation in factors such as calcium 
concentration, presence or absence of cargo, and/or phosphorylation of the heavy chain’s 
motor or tail, or on light chains (Sellers, 1999; Krementsov et al, 2004; Thirumurugan et 
al, 2006).  It is postulated that autophosphorylation of the myosin IIIa motor ay act as a 
means for its regulation in photoreceptors and inner ear hair cells under specific cellular 
conditions (Ng et al, 1996, Dosé et al, 2008).   
The particular cellular functions of myosin IIIa are currently under active 
investigation. It is known to be localized within the photoreceptors of invertebrates as 
well as vertebrate sensory receptor cells of the retina and cochlea.  It was first identified 
in Drosophila photoreceptors as the ninaC gene product (neither inactivating nor 
activating) that, when deleted, was associated with abnormal retinal lectrophysiological 
response and retinal degeneration (Montell and Rubin, 2088).  NINAC was demonstrated 
to require the motor but not the kinase domain in order to localize at the actin-bundle 
filled rhabdomere, a structure that is the primary site of phototransduction activity and 
thus is analogous to the vertebrate outer segment (Porter and Montell, 1993).  Other 
studies have demonstrated its ability to localize at the tips of actin bundles in 
photoreceptors of bass (Dosé et al, 2003) and Xenopus (Lin-Jones et al, 2004), as well as 
inner ear hair cell stereocilia of mice (Schneider et al, 2006) and filopodial tips in HeLa 
cells (Dosé et al, 2008).  Two isoforms designated myosin IIIa and IIIb have been 
identified in vertebrates (Dosé and Burnside, 2003, Dosé et al, 2003), and disruption of 
the human myosin IIIa gene has been associated with the development of non-syndromic 
deafness DFNB30 (Walsh et al, 2002; Vreugde et al, 2003). 
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Previous studies have indicated that actin bundle tip localization of my sin IIIa in 
filopodia and in stereocilia of inner ear hair cells is enhanced by removal of the myosin 
IIIA kinase domain (Dosé et al, 2008, Schneider et al, 2006).  A previously unknown 
compartment at stereocilia tips was found to expand in mouse cochleae transfected with 
kinase-deleted myosin IIIa (Schneider et al, 2006). This suggests that myosin IIIa may 
perform an essential role at stereocilia tips, with a potential regulatory function for the 
myosin IIIa kinase. Recently we have reported that myosin IIIa via its 3THD1 tail motif 
binds to the stereocilia-specific actin bundling protein espin I via its WH2 domain, 
myosin IIIa and espin I colocalize at stereocilia tips of mouse inn r ear hair cells and the 
filopodia tips of COS-7 cells, and that their cotransfection results in both stereocilia 
lengthening and a remarkable 10-fold lengthening of the filopodia (Salles et al 2009). 
While it is possible that myosin IIIa may transport essential components of the 
phototransduction pathway in Drosophila photoreceptors (Porter et al, 1993; Lee and 
Montell, 2004; Cronin et al, 2004), parallel functions have not been elucidated in the 
vertebrate eye.  
Our lab previously has reported kinetic analyses of myosin IIIa constructs 
truncated after the second IQ domain, with and without the kinase domain, des gnated 
myosin IIIa 2IQ and myosin IIIa 2IQ ∆kinase (Dosé et al, 2006; Dosé et al, 2008).  
Notable differences between the two constructs were found in steady state and transient 
kinetics as well as degree of filopodia tip localization.  The actin-activated ATPase assay 
for the kinase-deleted construct (MIIIa 2IQ ∆K) showed a two-fold higher kcat and five-
fold lower KATPase than MIIIa 2IQ, as well as five-fold higher steady-state ctin affinity.  
The rate-limiting step for MIIIa 2IQ was modeled to be a trnsition between two 
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AM.ADP states, while the faster MIIIa 2IQ ∆K exhibited slow, rate-limiting ATP 
hydrolysis. Another lab has recently reported similar results for a motor-only construct 
(Kambara et al, 2006), with differences that may be attributed to their removal of the 
lever arm and lower salt concentrations in assays (Dosé et al, 2008).  These results imply 
that kinase activity may be associated with down-regulation of the myosin motor. Results 
from experimentation on the kinase-removed construct have several cave ts, however.  It 
is possible that removal of the kinase domain may result in structural changes of the 
remaining molecule. Additionally, differentiation between effects due to 
autophosphorylation and those resulting from kinase-motor interactions is unclear.   
To more specifically identify the role of the kinase domain in motor regulation we 
have expressed and purified a kinase-dead construct, myosin IIIa 2IQ K50R, in which a 
critical lysine in the kinase catalytic domain has been substit ted with arginine to render 
the kinase domain incapable of autophosphorylating the motor. Cell localization studies 
in mouse stereocilia have been accomplished.  Additionally, we have examined the 
concentration dependence and role of actin filaments in the autophosphorylation process 
of our wild-type construct, MIIIa 2IQ, and have conducted a preliminary characterization 
of the steady-state enzymatic activity for fully phosphorylated MIIIa 2IQ.
 Previous results obtained by comparison of MIIIa 2IQ to MIIIa 2Q ∆K suggested 
that autophosphorylation may down-regulate the motor by reducing its affinity for actin. 
Our current study provides additional support for this hypothesis as well as additional 
data to clarify a model for the role of myosin IIIa in sensory cells, including the ability of 
the kinase to phosphorylate the motor in the presence of actin filaments and the 
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regulation of myosin motor activity by intermolecular autophosphorylation in a 
concentration-dependent manner. 
 
 
CHAPTER 3: MATERIALS AND METHODS 
3.1. Generation of Human Myosin IIIA cDNA Constructs 
  Reagents used were all of the highest purity available commercially.  ATP and 
ADP were prepared fresh from powder.  Nucleotides were prepared in the presence of 
equimolar MgCl2 before use.  [γ
32P]ATP was purchased from GE Healthcare Biosciences 
or PerkinElmer Life and Analytical Sciences Inc.   
 We previously generated a construct of human myosin IIIa containing residues 1-
1143, truncated after the second IQ domain (MIIIa 2IQ) and containing a C-terminal 
FLAG tag (DYKDDDDK) for purification purposes (Dosé et al, 2007; Sweeney, 1998; 
Sun et al, 2006).  The Stratagene QuikChange site-directed mutagenesis kit (Agilent 
Technologies) was used to modify this construct with a single point mutation, 
substituting arginine for lysine at residue 50 in the catalytic si e of the kinase domain 
(MIIIa 2IQ K50R), as described in Salles et al (2009). Expression plasmids were 
sequence verified by the University of Pennsylvania DNA Sequencing Facility. 
3.2 Expression and Purification of Proteins 
 
 
  Recombinant baculoviruses of MIIIa 2IQ, MIIIa 2IQ K50R, and calmodulin were 
generated with the FastBac system (Invitrogen). MIIIa 2IQ and MIIIa 2IQ K50R, 
respectively, were co-expressed with calmodulin (CaM).  One liter of insect Sf9 cells (2 x 
106 cells/ml) was co-infected with myosin and CaM viruses and cultured for three days at 
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28°C then harvested by centrifugation. Cells were lysed in 45 ml lysis buffer (10 mM 
Tris pH 7.5, 200 mM KCl, 1 mM EGTA, 1 mM EDTA, 2 mM MgCl2, 0.015 mg/ml 
aprotinin, 0.015 mg/ml leupeptin, 1 mM phenylmethylsulfonyl fluoride (PMSF), 2 mM 
ATP, 5 mM dithiothreitol (DTT)), and centrifuged (Beckman Coulter ult acentrifuge, 
Ti70 rotor) at 45 000 rpm for one hour. Myosin was separated on an anti-FLAG resin 
column and eluted with excess FLAG peptide.  The elute was further purified by 
ammonium sulfate precipitation then dialyzed overnight at 4°C in KMg100 buffer (10 
mM imidazole, 100 mM KCl, 1 mM EGTA, 1 mM MgCl2, 1 mM DTT).  Protein purity 
was assessed by Coomassie-stained SDS PAGE gels.  The Bio-Rad microplate Bradford 
assay was used to determine myosin concentration, with BSA as a st ndard (Dosé et al 
2006, Dosé et al 2008).  Absorbance measurements were also performed using a 
predicted extinction coefficient of 129 500 M-1 .cm-1 to calculate the concentration, with 
similar results. 
 Actin was purified from rabbit skeletal muscle using an acetone p wder method 
(Pardee and Spudich, 1982).  Actin was extracted in cold (4oC) G buffer (2 mM Tris-HCl 
pH 7.5, 0.2 mM ATP, 0.5 mM DTT, 0.2 mM CaCl4, 0.01% NaN3) and filtered, followed 
by polymerization at 4oC (addition of 50 mM KCl, 2 mM MgCl2, 0.8 mM ATP, and after 
2 hours in high salt wash to remove tropomyosin).  Following centrifugation pellets were 
resuspended in fresh G buffer and dialyzed for two days with buffer changes.  To 
enhance purity a second polymerization and depolymerization cycle was completed prior 
to use or liquid nitrogen storage.  Concentration was determined by absorb nce measured 
at 290 nm using an ε290 of 2.66 x 104 M-1 cm-1.  A molar equivalent of phalloidin (Sigma) 
was added to stabilize actin filaments in experiments. 
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All experiments were performed in KMg50 buffer (50 mM KCl, 1 mM EGTA, 
1mM MgCl2, 1 mM DTT and 10 mM Imidazole-HCl, pH 7.0, 25
oC) and in the presence 
of excess calmodulin to ensure that the IQ domains of MIIIa had bound calmodulin.  
3.3 Kinase Activity Assays 
 
 
 Autophosphorylation of MIIIa 2IQ and MIIIa 2IQ K50R was detected by kinase 
assay using [γ32P]ATP.  Myosin at specified concentrations was allowed to react with 200 
µM [γ32P]ATP at room temperature (~22oC) for specific time periods ranging from 0 to 
60 minutes.  The reaction was stopped at each time point by the addition of SDS loading 
buffer.  Autophosphorylation of MIIIa 2IQ K50R was compared to that of MIIIa 2IQ at 
1µM concentration, as was autophosphorylation of MIIIa 2IQ in the presenc  of 40 µM 
actin.  Additionally, autophosphorylation rates were compared at a series of myosin 
concentrations ranging from 0.1 to 1.2 µM.  Samples were run on SDS-PAGE gel and the 
incorporation of 32P into myosin IIIa was detected by phosphorimaging using the 
Typhoon 8600 Variable Mode Imager (Molecular Dynamics).  Following 
phosphorimaging, the gel was Coomassie-stained to assess evenness of loading.  
Densitometry analysis using NIH Image J software was used to e ermine band 
intensities and adjust for loading differences.   
3.4 Steady-State ATPase Activity 
 
 
 Steady-state ATP hydrolysis by MIIIa 2IQ K50R (50-100 nM) in the absence and 
presence of actin (0-60 µM) was examined by use of the nicotinamide adenine 
dinucleotide (NADH)-linked assay (Dosé et al, 2006) with a final MgATP concentration 
of 1mM.  This assay employs the NADH–lactate dehydrogenase–pyruvate kinase–
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phosphoenol pyruvate (NADH-LDH-PK-PEP) regeneration system to quantify the ATP 
hydrolysis rate by coupling regeneration of ATP hydrolysis product (ADP) to NADH 
oxidation, determined by monitoring for 200 s at an absorbance of 340 nm. The assay 
was performed in an Applied Photophysics stopped-flow.  The ATPase rate at each actin 
concentration was determined, and Michaelis-Menten equation was used to calculated the 
kcat and KATPase [Vo + ((kcat [actin])/(KATPase + [actin]))]. Uncertainties are reported as 
standard errors in the fits unless stated otherwise.  The data at each actin concentration 
represents an average of 2-3 protein preparations. 
 For comparing steady-state ATP hydrolysis rates of phosphorylated nd 
unphosphorylated MIIIa 2IQ at 20 µM actin, we pre-incubated the myosin (1-4 µM) at 
room temperature for 60 minutes with either 200 µM ATP or buffer, taking samples at 
specific time points (5, 15, 30, 60 min).  Myosin was diluted into the assay in the 
presence of 20 µM actin, ATP, and the regeneration system.  The ATPase rate as a 
function of time incubated was fit to a single exponential equation. 
 Steady-state actin-activated ATPase rates for both phosphorylated and 
unphosphorylated MIIIa 2IQ were obtained by preincubation of MIIIa 2IQ for 60 min (as 
described above) immediately prior to the assay.  Samples were tested in the presence of 
0 - 60 µM actin as described above.  Separate incubations were conducted for each 
ATPase sample using staggered start times to ensure that the l g time between incubation 
and testing was consistent.  
3.5 Actin Co-Sedimentation Assays 
 
 
 Steady-state actin affinity of MIIIa 2IQ K50R as well as phosphorylated and 
unphosphorylated MIIIa 2IQ was determined by actin cosedimentation.  The PK-PEP 
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ATP regeneration system was used to eliminate the accumulation of ADP.  Myosin (1 
µM) was mixed with actin (0-60 µM) in the presence of the regeneration system. 1-2 mM 
ATP was added prior to ultracentrifugation in a TLA 100.2 Beckman centrifuge at 95 000 
rpm for 20 min at 25° C. Supernatant and pellet were separated, the pellet was 
resuspended in KMg50-DTT buffer, and samples were run on SDS-PAGE gels. The 
fraction of actin-bound myosin was determined by measuring the relative amount of 
myosin in the pellet sample normalized to the total (supernatant + pellet).  Quantification 
of bands and densitometry analysis were performed using Image J software (NIH).  
Kaleidagraph software was used to fit the data to a binding equation.  
 
 
 
CHAPTER 4:  RESULTS 
 
4.1 Kinase-Dead Mutant MIIIA 2IQ K50R 
 The expression yields of MIIIa 2IQ K50R co-expressed with calmodulin in the 
baculovirus insect cell (sf9) system were comparable to those for MIIIa 2IQ in this and 
our previous studies (Dosé et al 2006; Dosé et al 2008). The purity of both MIIIa 2IQ 
(WT) and MIIIa 2IQ K50R after anti-FLAG affinity column chromatography was 
assessed to be 95% by Coomassie staining following electrophoresis in SDS-PAGE gel 
(expected molecular weight for each construct was 131 780 Da).  Stoichiometry for 
calmodulin to myosin was determined to be approximately two to one. 
 All experiments were performed in KMg50 buffer in the presence of 10-
fold excess calmodulin to ensure that all IQ motifs were calmodulin-bound.  Conditions 
and methods for experiments were identical to those in our previous kinetic 
characterizations of MIIIa 2IQ and MIIIa 2IQ ∆K (Dosé et al 2006, Dosé et al 2008) 
unless otherwise indicated, which allow direct comparison with the current kinase-dead 
and fully-phosphorylated myosin IIIA analyses.  We investigated properties of the
phosphorylation process in addition to the steady-state activity of a fully phosphorylated 
MIIIa 2IQ.  Full phosphorylation was accomplished by incubation of myosin with 200 
µM ATP in the presence of 10 µM calmodulin (at room temperature, 60 minutes) as 
described in Dosé et al (2006), then immediately used in the assay. 
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 The elimination of kinase activity by the K50R point mutation was evaluated by 
Western blot of samples taken at specific time points during 60 minutes of incubation 
with 200 µM ATP, using antiphosphothreonine as the primary antibody (Figure 1).  No 
phosphothreonine increase was detected at a myosin concentration of 0.5 µM, whereas 
the myosin IIIa 2IQ wild type protein (0.5 µM) showed similar rates of increase in 
phosphorylation to our previous reports (Dosé et al, 2006). Prior to incubation (0 min) the 
K50R myosin showed a residual level of threonine phosphorylation slightly higher than 
was previously seen and reported for the wild type control (Dosé et al, 2006). 
Nitrocellulose membranes were stripped and reprobed with anti-FLAG to evaluate 
evenness of protein loading for each sample.  
4.2 Myosin Concentration Dependent Autophosphorylation 
To determine whether autophosphorylation of myosin IIIa is an intermolecular or 
intramolecular process, we performed time-course kinase assays in the presence of 200 
µM (γ32-P) ATP as described in Materials and Methods, at a series of my sin 
concentrations between 0.1 µM and 1.2 µM.  Phosphorimages of representative SDS-
PAGE gels from one experiment are shown in Figure 2C (0.1, 0.3, 0.6 and 1.2 µM). After 
phosphorimaging, gels were Coomassie-stained to determine total protein levels. 
Densitometry analysis was used to determine the time course of phosphate incorporation 
at each concentration based on the phosphorylated band intensity relative to total protein 
levels.  Results are averaged from 3-4 separate experiments on three different protein 
preps. 
We found that autophosphorylation rates were nearly linearly dependent on 
myosin concentration within the range tested (Figure 2, A and B).  Rates obtained were 
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as follows: at 0.1µM, 0.049 ± 0.035 min-1; at 0.3 µM, 0.116 ± 0.029 min-1; at 0.6µM, 
~0.207 ± 0.064 min-1; and at 1.2µM the rate was 0.289 ± 0.060 min-1.  The data were fit 
to a hyperbolic equation [kinase activity / (sec * [MIII])] → [kinase activity (relative) / 
(sec * [mM M3])] to estimate the maximum kinase activity rate. The dependence of 
phosphorylation rate on myosin concentration suggests an intermolecular process for 
autophosphorylation in MIIIa 2IQ.  
4.3 Actin Concentration Independent Autophosphorylation 
An early study predicted that the autophosphorylated residue(s) of the human 
myosin IIIa motor is/are within a 20-kDa segment at its C terminus, near loop 2 of the 
motor’s actin-binding region (Komaba et al 2003). In order to determine whether the 
MIIIa motor in the presence of actin is autophosphorylatable in the sam  way as myosin 
alone, we performed parallel time-course kinase assays incubating myosin IIIa 2IQ in the 
absence and the presence of 40 µM actin with 200 µM (γ32P)ATP. Kinase assays were 
performed as described in Materials and Methods, and results were visualized by SDS-
PAGE and phosphorimaging, as well as Coomassie staining (Figure 3B).  y 
densitometry analysis we determined that the presence of actin had no appreciable 
influence on phosphorylation rate (Figure 3A).  Results are averaged from 3-4 separate 
experiments on three different protein preps. 
4.4 Steady State ATPase Activity 
We evaluated the steady-state enzymatic activity of MIIIa 2 Q K50R as compared 
to that of the wild-type MIIIa 2IQ construct in its phosphorylated state, using the NADH-
coupled actin-activated ATPase assay as described in Materials and Methods (Figures 4A 
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and 4B).    The unphosphorylated control MIIIa 2IQ was treated in parallel with 
phosphorylated samples but in the absence of ATP.   
We plotted the ATPase activity as a function of actin concentration nd used the 
Michaelis-Menten equation to determine kcat and KATPase.  As previously reported the 
maximal ATPase activity (kcat) for the kinase dead construct was 0.76 ± 0.08 sec
-1 (Salles 
et al 2009), while the actin concentration at one-half maximum ATPase activity, KATPase, 
was 11.9 ± 3.7 µM (Figure 4B).  The kcat for the kinase dead construct is comparable to 
our previous results on MIIIa 2IQwt (0.77 ± 0.08 sec-1), but its KATPase was 3-fold lower, 
intermediate between MIIIa 2IQ (34 ± 11µM) and MIIIa 2IQ ∆K (1.4 ± 0.04 µM) (Table 
1) (Salles et al, 2009, Dosé et al, 2007, Dosé et al, 2008).  
We evaluated the effect of phosphorylation on MIIIa 2IQ’s steady-state rate of 
ATP hydrolysis at a constant actin concentration (Figure 4A).  MIIIa 2IQ (1 µM) was 
incubated with 200 µM ATP at room temperature (~22oC) and samples were taken at four 
time points during the phosphorylation process (5, 15, 30, 60 min) to be imm diately run 
in the assay in the presence of 20 µM actin and the regeneration system.  A buffer-treated 
control at the same concentration was assayed in parallel with each sample (Figure 4A).  
Results indicate that, compared to the control, enzymatic activity was reduced as myosin 
phosphorylation progressively increased.  After 60 minutes of incubation the ATPase rate 
for phosphorylated MIIIA 2IQ at 20 µM actin was 0.099 ±0.057 sec-1, a reduction in 
activity of approximately 40% relative to the control.  Room temperature buffer treatment 
did not appreciably alter the control myosin’s ATPase rate of 0.245 ± 0.067 sec-1. Results 
are averaged from 3-4 separate experiments on three different protein preps. 
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We measured the steady-state actin-activated ATPase activity of fully 
phosphorylated MIIIA 2IQ with a range of actin concentrations (0-40 µM) and compared 
it to unphosphorylated controls. Our results indicate that the maximum ATPase rate (kcat) 
was reduced by phosphorylation (0.25 ± 0.077 sec-1 compared to 0.78 ± 0.30 sec-1) as 
was the KATPase (2.38 µM ± 3.38 compared to 24.9 µM ± 19.7 for unphosphorylated) 
(Figure 4B).  Results for the controls were similar to those btained in our previous 
analysis of untreated MIIIa 2IQ (Dosé et al, 2007). 
4.5 Steady State Actin Affinity 
 We determined the steady-state actin affinity of myosin IIIa 2IQ K50R in the 
presence of ATP and the PK-PEP regeneration system using a co-sedimentation assay as 
described in Materials and Methods. The fraction of myosin that bound to actin was 
plotted as a function of actin concentration (0 – 40µM), and fit to a hyperbolic equation 
to determine the steady-state actin affinity (KActin) of 3.83 ± 0.53 µM.  This value is 
intermediate between previous results obtained for the wild type MIIIa 2IQ and  kinase-
deleted MIIIa 2IQ ∆K (7.0 µM ± 0.6 µM and 1.4 ± 0.4 µM, respectively) (Figure 5A and 
B, MIIIa 2IQ K50R).  Results represent the average from three separate experiments 
from two different protein preparations. 
The actin co-sedimentation assay was also performed on fully phosphorylated 
MIIIa 2IQ in parallel with buffer-treated controls.  Samples of phosphorylated and 
unphosphorylated control MIIIa 2IQ were prepared as described above (60m incubation 
at room temperature in the presence and absence of 200 µM ATP) and immediately run in 
the assay at 1 µM concentration.  As seen in Figure 5, the steady-state actin affinity of 
phosphorylated MIIIA 2IQ was lower than the control, with a KActin (actin concentration 
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at one-half maximum) of 15.60 µM ± 2.43 as compared to 5.48 ± 1.16 for the control.  
Phosphorylation was consistently associated with reduced maximum fraction of actin-
bound myosin (~0.65% vs. ~0.86%).  (Figure 5B, phosphorylated and control).  Results 
represent the average from 3-5 experiments on 2-3 different protein preparations. 
 
 
 
CHAPTER 5: DISCUSSION 
 Previously our lab characterized the motor enzymatic activity using a kinase-
removed construct (MIIIa 2IQ∆K) and compared its enzymatic properties to those of its 
wild-type counterpart MIIIa 2IQ (Dosé et al 2006, Dosé et al 2008). Without the 34 kDa 
kinase domain the myosin IIIa motor demonstrated a 2-fold higher maximal ATPase rate 
and 5-fold tighter actin affinity, which suggests it behaves as an unregulated motor and 
therefore suggesting that phosphorylation may serve as a downregulatory mechanism. 
Our current study provides further insight by eliminating the potentially confounding 
influences associated with complete removal of the kinase domain by comparing the 
enzymatic activity of the recently-developed kinase-dead construct (MIIIa 2IQK50R) 
(Salles et al 2009) with those of  a fully phosphorylated MIIIa 2IQ.  We also repo t that 
the autophosphorylation process occurs intermolecularly and is independent of actin 
concentration, properties that are relevant to the regulation of myosin IIIa’s function in 
the cell. These investigations provide, in conjunction with our earlier studies, a more 
direct evaluation of the properties and effects of myosin IIIa motor autophosphorylation.  
We also include corroborating evidence from immunolocalization studies using GFP-
tagged versions of our constructs transfected into mouse stereocilia, wh ch add important 
information for further clarification of the model. 
 The results of our kinase assays show that the rate of autophosphorylation 
increases with myosin concentration across the range of 0.1 µM to 1.2 µM, which 
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indicates that the autophosphorylation process takes place in an intermolecular manner in 
this concentration range. That is, myosin IIIa kinase domains phosphorylate other myosin 
IIIa target residues on nearby molecules rather than (or in addition to) sites within the 
same myosin IIIa protein. This suggests that as myosin IIIa motor activity propels 
individual molecules to actin bundle tips they join others accumulated in its tip 
compartment.  As concentrations of myosin IIIa increase in the tip compartment myosin 
IIIa can phosphorylate other nearby myosin IIIa molecules and downregulate the ATPase 
activity as well as actin affinity. 
 Since myosin IIIa functions in actin-rich regions in the cell, we investigated the 
autophosphorylation process in the presence of actin. We conducted kinase assays in 
parallel in the presence and absence of actin filaments (40 µM concentration), and found 
that autophosphorylation rate and degree were not altered by actin in vitro.  It appears 
that the motor’s target residues for phosphorylation remain equally accessible to the 
kinase under either condition.  Our results suggest a model in which the onc ntration of 
myosin IIIa localized to the compartment at the end of its bundled actin filament “track” 
is regulated by autophosphorylation in a concentration-dependent manner. 
 We recently developed the myosin IIIa construct MIIIa 2IQ K50R with a point 
mutation at the critical lysine in the catalytic region of the myosin’s kinase domain to 
abolish ATP catalysis and thus render it non-functional as a kinase, while otherwise 
retaining its full sequence (Salles t al 2009). We showed by Western blot analysis using 
the antiphosphothreonine antibody that the K50R construct had relatively littl  increase 
in threonine phosphorylation under our assay conditions.  The wild-type myosin IIIa 
demonstrated threonine phosphorylation which reached saturation over a one-hour time 
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course.  This is in agreement with previously published phosphorimaging results showing 
no phosphorylation increase for K50R with the same treatment conditions usi g 
radiolabeled ATP (Salles et al 2009).  Western blotting provides the additional 
information that, for both MIIIa 2IQ wild type and MIIIa 2IQ K50R, an initial level of 
threonine phosphorylation can be detected prior to beginning the assay.  Initial wild type 
phosphorylation was also detected previously and was attributed to the activity of an 
exogenous kinase in the Sf-9 cells during the culturing process (Dosé et al 2006). 
Interestingly, Pak1 kinases have a highly conserved serine/threonine res due that requires 
phosphorylation for activation of kinase activity (Liu et al 2006, Pirruccello et al 2006).  
This serine/threonine can be readily phosphorylated by either exogenous or activated 
Pak1 kinases in an intermolecular fashion (Pirruccello t al 2006).  The corresponding 
conserved residue in myosin IIIa is T184. 
 Of interest is the observation that initial phosphorylation levels are consistently 
high for K50R, whereas initial phosphorylation levels for the wild type construct are 
typically low.  We have found that, in contrast to K50R, those wild-type preps that 
exhibited heavier initial phosphorylation also showed low activity in the steady-state 
ATPase.  Our interpretation is that when a wild-type myosin IIIa prep shows heavy initial 
phosphorylation, activated kinase domains have already phosphorylated targ t sites on 
the motor and therefore we cannot use it to make comparisons between phosphorylated 
and dephosphorylated parameters. The kinase domain of the K50R construct has been 
rendered unable to phosphorylate either kinase or motor target residues, so it is likely that 
the K50R kinase activation site and/or another kinase domain phosphorylation target is 
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more readily accessible to an exogenous kinase and becomes phosphorylated under 
culture conditions, while the motor remains unphosphorylated.  
 Because a major goal was to investigate the effects of phosphorylation on the 
MIIIa motor, we evaluated the steady state enzymatic and actin binding activity of the 
K50R construct as representative of an unphosphorylated motor that will not become 
phosphorylated during an ATP-containing assay. This provided a point of reference for 
comparison with the steady-state activity of a fully phosphorylated myosin IIIa motor.  In 
the ATPase assay we found the kinase-dead construct to differ from both phosphorylated 
and untreated/buffer-treated wild type MIIIa 2IQ in its actin-bi ding properties (KATPase 
and KActin) while the maximum rate of actin-activated enzymatic activity (kcat) was 
unchanged between K50R and untreated wild type but reduced for phosphorylated MIIIa 
2IQ.   In the actin cosedimentation assay reported herein we found a KActin that was 
approximately 2-fold tighter than wild type (3.83 µM vs 7.0 µM), while the fully 
phosphorylated myosin had a higher KActin than either of these (See Table 1).   
 The pretreatment for full phosphorylation reduced the kcat  of the ATPase assay 
from its wild type value while the previously-reported kinase deletion increased it, yet the 
K50R point mutation did not cause a difference from untreated wild-type values. We 
attributed the enhanced maximum ATPase activity of the ∆K construct to a faster 
transition between two actomyosin-ADP states, which is the rate limiting step for wild 
type myosin IIIa (Dosé et al 2006, Dosé et al 2008). The MIIIa∆K construct has shifted 
its rate limiting step to ATP hydrolysis. Phosphorylation, on the otr hand, may slow the 
transition from the intermediate to the high affinity AM.ADP state, or altenatively it may 
cause a large increase in the population of myosin inhabiting a previously observed off-
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pathway low affinity M.ADP state (Dosé et al 2008, Dosé et al 2006). An increase in the 
population of the off-pathway AM.ADP state could reduce the overall kcat because the 
rate of ADP release for this state may be slowed. It is likely, given the slow rate of 
autophosphorylation at the assay’s myosin concentrations (~.05 min-1 at 0.1 µM), that not 
enough autophosphorylation can take place during the 200-second timecourse of the 
ATPase assay to effect a measurable change in kcat, and so only a small difference is noted 
between untreated/buffer-treated wild type and K50R. 
 In our timecourse ATPase assays we monitored the changes i steady-state 
ATPase rate at 20 µM actin as the time of pre-incubation with ATP increased. We found 
a progressive reduction to approximately 40% of the initial rate aftr one hour of 
incubation, which agrees in principle with the results from the full-range ATPase assays 
using fully phosphorylated myosin.  However, our results from the full assay show little 
if any difference at 20 µM actin.  One difference between the two assays was in the 
myosin concentration during pre-treatment (1 µM for the timecourse, 4 µM for the full-
range assay). The change in pretreatment conditions improved the preservation of myosin 
ATPase activity for both experimental and control samples, correcting an inconsistency 
experienced with this assay. It is difficult to ascertain how this change might result in the 
difference noted, but the high-concentration pretreatment may have resulted in more 
thorough phosphorylation.  Another possible explanation is that, during the time the full-
range assays were being conducted, our preps tended to show more initial 
phosphorylation than the earlier preps used for the timecourse assays.  As noted earlier, 
higher initial phosphorylation tended to correlate with lower activity n the ATPase in the 
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untreated and buffer-treated state, and so the assay required higher actin concentrations to 
distinguish the effects caused by additional phosphorylation.  
 Both ATPase and actin cosedimentation steady-state assays showed the K50R 
actin affinity to be intermediate between wild type and the pr viously reported high 
affinity seen for the kinase deleted construct (Dosé et al 2008), while the fully 
phosphorylated MIIIa sample exhibited reduced KATPase and increased KActin.. While both 
these measurements are used to describe steady-state actin affini y, they are obtained in 
different ways.  Both employ ATP regeneration systems to minimize the buildup of ADP 
during the assay, which has the potential to compete with ATP at themotor’s nucleotide 
binding site, but the time period during which the regeneration system must work is very 
different.  If phosphorylation influences the rate of transition between AM.ADP states, 
then the presence of additional ADP in the system may affect phosphorylated MIIIa 
differently than unphosphorylated. The ATPase assay is monitored as it progresses over 
200 seconds after a brief time during which reagents are mixed and lo ded into the 
stopped-flow.  On the other hand, the actin cosedimentation assay takes slightly longer to 
mix and load into the centrifuge, while the centrifugation step takes 20 minutes. Thus 
there is a greater likelihood of ADP buildup during the cosedimentatio  ssay in spite of 
the regeneration system. If, as described, motor phosphorylation causes  hift in 
equilibrium so that the transition from the intermediate affinity AM.ADP state to the off-
pathway low affinity AM.ADP state becomes more favored and the transition to the high 
affinity state is either slowed or not appreciably affected, the presence of ADP may be 
inhibitory for one or both of these transitions.  The different balance in populations of the 
three AM.ADP states due to the presence of excess ADP would be reflected in an overall 
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KActin for phosphorylated MIIIa 2IQ that is higher than that seen in the unphosphorylated 
MIIIa 2IQ.  
 In collaboration with this work, the Kachar lab (NIH) has completed an analysis 
of full length GFP-tagged myosin IIIa K50R, ∆K and wild type transfected into mouse 
stereocilia, and those results will be published in conjunction with our data described 
herein. This is a follow-up to their immunolocalization studies in which they transfected 
GFP-tagged full length versions of our myosin IIIa constructs into COS-7 cells (Salles et 
al., 2009) so that their localization characteristics in an endogenous environment could be 
investigated (See Appendix, Supplemental Figure 1). As was seen in filopodia of COS-7 
cells, myosin IIIa localized primarily to the tips of actin bundles in stereocilia, with more 
pronounced localization seen for the K50R construct and especially so for ∆K, both of 
which appear to expand the tip compartment compared to stereocilia transfected with 
wild type. Differences in the actin treadmilling rate of stereocilia, where treadmilling is 
slow, and filopodia, where treadmilling is more rapid, are expected to affect net velocity 
of myosin IIIa toward the tips and thus account for the more efficient wild-type myosin 
IIIa tip localization in stereocilia (Salles et al 2009). The longer stereocilia in the 
grouping on a given hair cell appear to have a higher concentration of myosin IIIa than 
the shorter ones seen in transfected wild type and K50R cells. The ∆K-transfected 
stereocilia in this image appear to all have high concentrations of myosin and are all of 
similar length rather than exhibiting the characteristic staircasing seen for transfections of 
the other myosin IIIa constructs.  The observed relationship between myosin IIIa 
concentration and stereocilia length is logical for a myosin whose cellular role involves 
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maintenance of the length of actin bundles in structures that must main ain a precise 
length for function..   
 Our results suggest that the ability to autophosphorylate its motor is important for 
myosin IIIa down regulation, potentially in conjunction with maintaining the appropriate 
concentration of its cargo, the actin-bundling protein espin I.  The combination of myosin 
IIIa motor regulation and espin I actin-bundling function may serve to maintain the actin 
bundle core at the required stereocilia length for a hair cell’s auditory 
mechanotransduction response. Salles et al (2009) suggest that, rather than dissociating 
from one another, the myosin IIIa-espin 1 complex may be assimilated into and 
maintained within the actin bundle core as a unit so that the entire complex is carried to 
the stereocilia base by the actin treadmilling process. 
 It may be further speculated that in addition to espin 1 transport myosin IIIa 
performs other as yet undetermined role(s) when localized to stereocilia tips, which are 
also the site of mechanoelectrical transduction (MET).  It was demonstrated that 
maturation of MET is developmentally correlated with onset of myosin IIIa expression 
above detectable levels (Waguespack et al, 2007), and it is suggested that myosin IIIa 
may be able to bind other membrane proteins with ankyrin repeats similar to those on the 
espin 1 WH2 domain (Salles et al 2009).  The lack of down regulation associated with 
the non-functional kinase constructs has the potential to contribute to excessive 
lengthening of actin bundles by several means. 
 Phosphorylation is utilized as a regulatory mechanism for the activity of many 
members of the myosin superfamily.  Not only is regulatory light chain phosphorylation 
necessary to activate the smooth muscle and non-muscle myosin II ATPase, but there are 
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also many examples of regulation by heavy chain phosphorylation. Non-muscle myosin 
II phosphorylation near the C-terminus of its tail region appears to down-regulate its 
activity by inhibiting filament formation and/or directly influenci g its actomyosin 
ATPase.  Tail phosphorylation appears to similarly influence activity of some 
unconventional myosins by affecting tail binding characteristics (Brzeska and Korn 1996 
review). Some lower eukaryotic myosin I isoforms are activated by motor 
phosphorylation targeting a specific serine or threonine residue in an actin-binding 
surface loop (the TEDS site).  Interestingly a Pak1-like myosin heavy chain kinase whose 
catalytic region is similar to the myosin IIIa kinase domain phosrylates the TEDS site 
(Bement and Mooseker 1995, Brzeska and Korn 1996 review, Redowicz 2001 review). 
Actin-activated kinetics of the myosin VI motor are likewise modulated by 
phosphorylation by a cellular Pak kinase at a threonine residue in its TEDS site (De La 
Cruz et al 2001).  However, the myosin IIIa motor phosphorylation does not appear to be 
at the TEDS residue since there is a glutamic acid at this site in myosin IIIa (Bement and 
Mooseker 1995; De La Cruz et al 2001; Dosé et al 2003). 
 The C-terminal portion of the myosin IIIa motor domain identified as its 
autophosphorylatable region (Komaba et al 2003) contains loop 2, which is a surface 
loop in the actin-binding region that is thought to alter actin affinity and actin-activated 
product release in myosin II and myosin V (Uyeda et l 1994, Joel et al 2003, Yengo and 
Sweeney 2004).  The net positive charge in this loop appears to be a det rmining factor 
mediating actin affinity, and so the reduction in charge resulting from phosphorylation 
may be expected to reduce actin affinity (Joel et al 2003, Yengo and Sweeney 2004, 
Kempler et al 2007). It has recently been reported that Limulus myosin IIIa (Lp-MYO3), 
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an invertebrate myosin responsive to circadian rhythms but without funcional motor 
activity, has two autophosphorylatable serines within its loop 2 region (Cardasis et al 
2007, Kempler et al., 2007). Loop 2 phosphorylation has not been demonstrated for any 
other class of myosin, but variability in the loop’s sequence and flexibility among 
members of the myosin superfamily is a well-documented contributor to myosin motor 
diversity (Uyeda et al 1994, Joel et al 2003, Yengo and Sweeney 2004). 
 The presence of actin did not alter autophosphorylation in spite of the possible 
target residue’s position on or near loop 2 of the motor’s actin binding region.  It may be 
that the target residue is not in direct contact with the actin filament, and so transfer of the 
relatively small phosphate group is not blocked sterically.  Alternatively, phosphorylation 
may occur in the weak binding states when myosin IIIa is detached from actin. 
 In summary, our results provide strong support for the hypothesis that 
autophosphorylation of the myosin IIIa motor domain serves to reduce steady-state actin 
affinity as a means of downregulating motor activity.  Our kinase-dead, and thus 
presumably unregulated, K50R mutant demonstrated enhancement of in vitro steady-state 
actin affinity (lowered KATPase and KActin) in the actin-activated ATPase and actin 
cosedimentation assays.  In contrast, the fully phosphorylated MIIIa 2 Q construct 
exhibited relatively reduced kcat and increased KActin in the steady-state in vitro assays, 
along with progressive reduction in steady-state ATPase activity at a constant actin 
concentration as phosphorylation levels increase over time.  
 Our model of myosin IIIa functionality in inner ear hair cells, which is 
diagrammed in figure 6, proposes that the unphosphorylated myosin molecule 
translocates to actin bundle tips carrying espin I as its cargo.  Upon arrival its kinase 
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domain may phosphorylate other myosin IIIa molecules in its vicinity at the tips, a 
process whose likelihood increases with myosin IIIa (and thus espin I) concentration. 
Inactivation of the myosin motor and/or reduction in actin affinity will result in 
detachment from the actin bundle and subsequent removal from the area by ither 
diffusion or by actin treadmilling due to maintenance of espin 1 binding or if the actin-
binding tail domain remains attached to recycling actin monomers. A possible 
consequence of rapid phosphorylation at high myosin concentrations may be that the 
espin I cannot become incorporated into actin bundle tips before myosin motor 
phosphorylation and inactivation causes it to be removed from the vicinity. This scenario 
provides a possible mechanism for myosin IIIa/espin I maintenance of st reocilia length 
in inner ear hair cells. It is also possible that myosin IIIa, espin I, or the myosin IIIa-espin 
I complex may interact at stereocilia tips with components of the MET machinery (Salles 
et al 2009).  
 The biological events modeled for myosin IIIa activity require a regulation 
strategy not only for phosphorylation via the myosin IIIa kinase domain but also for its 
dephosphorylation.  However, the cellular phosphatase responsible for dephosphorylating 
the target serine/threonine residues on myosin IIIa motor and kinase domains in vivo has 
not yet been identified, and future studies on the dephosphorylation processes involved 
will be required for clarification. The bulk of serine-threonine dephosprylations are 
catalyzed by a handful of phosphatase catalytic subunits that, in the absence of their 
regulatory subunits, appear to be promiscuous and unregulated enzymes (Gall go and 
Virshup, 2005; Virshup and Shenolikar, 2009). In vivo, however, these subunits combine 
so that the diverse regulatory components confer selectivity, localization, and regulation 
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to the individual phosphatase (Gallego and Virshup, 2005; Virshup and Shenolikar, 
2009). Previously we have successfully dephosphorylated purified myosin IIIa using 
catalytic subunits of both calf intestinal phosphatase (CIP) and protein phosphatase type 1 
(PP1) (data not shown).  Determination of specific targeting subunits of serine/threonine 
phosphatases involved and their localization in stereocilia will be important to building 
an understanding of the reversibility of this signaling pathway (Ceulemans and Bollen, 
2004; Gallego and Virshup, 2005).   
 Further characterization of human myosin IIIa motor regulation by 
autophosphorylation will also include phosphorylation site determination and direct 
investigation of the regulatory properties of each site by mutagenesis. In addition, a 
complete kinetic characterization of the phosphorylated myosin IIIa enzymatic cycle will 
ascertain its specific steps that are directly affected by autophosphorylation.  Finally, in 
vitro motility assays of full-length myosin IIIa, both phosphorylated and 
unphosphorylated, will provide important data concerning its motility on actin filaments 
in either state. These characterizations will provide further clarifi ation of the 
mechanism(s) whereby myosin IIIa contributes to the hearing process.  Such studies may 
also have further implications regarding the proposed role for myosin IIIa in 
morphogenesis and maintenance of actin bundles at vertebrate photoreceptors (Lin-Jones 
et al 2004). Comparison of the two isoforms, myosin IIIa and myosin IIIb, will be critical 
for understanding the role of myosin III in sensory cells.  
 The broad goals for understanding myosin IIIa function and regulation re to 
develop a more complete picture of the auditory and visual sensory processes, which will 
provide a basis upon which treatments for hearing or visual disorders may be developed.   
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For example, regulation of myosin IIIa kinase activity may be critical when specific 
signaling pathways in which myosin III is involved become elucidated. Therapies 
targeting specific steps in kinase-dependent signaling pathways have been well utilized in 
the drug development industry.  Finally, understanding the regulation of the motor and 
kinase activity of myosin III will allow us to develop the necessary tools to dissect it  role 
in the sensory transduction process in vivo. 
 
  
   
 
 
CHAPTER 6:  SUMMARY AND CONCLUSIONS 
 This dissertation reports our findings on the steady-state enzymatic ch racteristics 
and actin-binding properties of both fully-autophosphorylated and kinase-dead myosin 
IIIa 2IQ.  It also shows that the autophosphorylation process is intermolecular, as 
evidenced by a rate that is dependent on the myosin concentration, and that it takes place 
at the same rate whether actin filaments are present or not.  We present a model of 
myosin IIIa activity in the stereocilia of inner ear hair cells that describes concentration-
dependent downregulation of the myosin IIIa motor by autophosphorylation as a vital 
component of its role in parallel actin bundles such as those in stereocilia.  Finally, we 
suggested lines of further investigation that are necessary to clarify specific aspects of 
myosin IIIa regulation as it contributes to maintenance of stereocilia structure in the 
hearing process. 
 In addition to the results presented in these chapters, the Appendix that follows 
includes data collected and analyzed for previously published work and results from 
unpublished experiments that furthered our understanding of myosin IIIa autoreg lation 
and gave focus to the dissertation.   
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Figure 1. The myosin IIIa kinase domain was inactivated by the K50R mutation. A. The 
K50R mutation abolished autophosphorylation in the MIIIa 2IQ K50R mutant as 
compared to full phosphorylation of the wild type construct in the time course kinase 
assay (1.0 µM MIIIa, 200 µM ATP, 20° C) as evidenced by Western blotting, using 
antiphosphothreonine as the primary antibody.  Stripping and reprobing with antiflag 
reveal relative protein levels per lane. B. Densitometry analyis of Western results. The 
observed high initial levels of threonine phosphorylation have been attributed to kinase 
phosphorylation in cell culture (See Discussion).  Previously-published phosphorimaging 
results for K50R showed no incorporation of  32P from (γ-32P)ATP incubation as 
compared to wild type MIIIa 2IQ (Salles et al 2009). 
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Figure 2.  Autophosphorylation rates were found to be dependent upon myosin 
concentration.  Myosin concentration dependence suggests that autophosphorylation is an 
intermolecular event across the range of 0.1- 1.2 µM myosin IIIa 2IQ, treated with 
200µM (γ32-P)ATP.  A. Phosphorimages of representative phosphorylation time courses 
at 0.1, 0.3, 0.6, 1.2 µM myosin IIIa 2IQ, and B. densitometry analysis of a representative 
experiment. C. The rate of autophosphorylation ranged from 0.049 min-1 at 0.1 µM MIIIa 
to 0.289 min-1 at 1.2 µM MIIIa, with a Vmax of 0.537 ± 0.047 (Error bars indicate 
standard deviation from 3-4 assays on 2-3 different protein preps.)  
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Figure 3.  The presence of actin does not alter the rate of myosin IIIa 
autophosphorylation. A. The rate of autophosphorylation (γ-32P incorporation) by 1 µM 
MIIIa 2IQ was unchanged in presence of 40 µM actin. (0.0018 ± 0.004 s-1 vs 0.0023 ± 
.0004 s-1) Error bars represent standard deviation from 5-6 different assays using protein
from several different preps. B. Representative timecourse of γ-32P incorporation (0-60 
m) in the presence and the absence of actin (phosphorimage). Coomassie staining 
indicates relative levels of total protein.   
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Figure 4. Steady-state actin-activated ATPase parameters for MIIIa 2IQ are influenced by 
phosphorylation status and by a non-functional kinase.  A.  As autophosphorylation 
progresses over time (0-60 min) the actin-activated ATPase rate (20 µM actin) decreases. 
Pretreatment of myosin (1 µM) was conducted as described, then diluted to 0.1 µM for 
the assay.  B.  While phosphorylation of MIIIA 2IQ reduces kcat and KATPase in the actin-
activated ATPase assay, the K50R kinase dead mutation reduces KATPase without 
changing kcat from untreated MIIIa 2IQ values.  Myosin concentration for pretreatment 
was 4 µM, and was diluted to 0.1 µM for the assay. (See Table 1 and Materials and 
Methods). 
B. 
A. 
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Figure 5. The steady-state affinity of MIIIa 2IQ K50R for F-actin in the presence of ATP 
as compared to untreated and phosphorylated MIIIa 2IQ.  The actin cosedimentation 
assay was used to determine steady state actin affinity for (A) K50R vs untreated and (B) 
K50R vs phosphorylated and buffer-treated control wild type. Myosin (1.0 µM) was 
equilibrated in the presence of various concentrations of actin, ATP, and the ATP-
regeneration system and then pelleted at 25 °C. The fraction of myosin bound to actin 
was quantified by densitometry analysis following Coomassie staining of SDS-PAGE 
gels. The plot of the fraction bound as a function of actin concentration was fit to a 
hyperbola to determine the steady-state affinity for actin. Error bars rep esent the 
standard deviation from 3-5 separate experiments performed on 2-3 different protein
preparations. See Table 1 for values. 
 60 
1. Cargo transport
2. Kinase autophosphorylation3. Motor auto-
phosphorylation
4. To be recycled by        
dephosphorylation
(cellular phosphatase)
 
 
Figure 6.  Model of myosin IIIa function in inner ear hair cells.  1.  (lower right) Myosin 
IIIa with its cargo, espin 1, attached to its 3THD1 domain, walks up the actin bundle by 
motor activity and using the actin binding motif in its tail tip 3THDII domain to maintain 
processivity. 2.  (upper right) Myosin IIIa may or may not release espin 1 at the tip of the 
actin bundle,  Tail domains with or without espin 1 may remain attached to actin or, 
alternatively, bind with other binding partners at the tail tip. 3.  (upper left) A cellular 
kinase (or another activated myosin IIIa kinase) phosphorylates the kinase domain t  
activate it, and it may act as a signaling protein to phosphorylate other target molecules. 
Other activated myosin IIIa kinases in the vicinity phosphorylate the myosin IIIa motor, 
reducing its actin affinity. 4. (lower left) Fully phosphorylated myosin IIIa returns to the 
base of the stereocilium by retrograde flow as it maintains association wi h the actin 
bundle. Alternatively, it may detach from the actin bundle and diffuse away from it. 5.  
The kinase and the motor are dephosphorylated by a cellular phosphatase.
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Steady-State Parameters 
MIIIa 2IQ 
Untreated 
MIIIa 2IQ 
K50R 
MIIIa 2IQ 
Phos 
MIIIa 2IQ 
Dephos 
aV0 (sec)-1 0.07 ± 0.03 0.07 ± 0.05 0.16 ± 0.06 0.05 ± 0.04 
bkcat (sec)-1 0.77 ± 0.08 0.76 ± 0.08 0.25 ± 0.08 0.78 ± 0.30 
cKATPase (µM) 34 ± 11 9.42 ± 1.68 2.38 ± 3.40 25.0 ± 19.7 
dKActin (µM) 7.0 ± 0.60 3.83 ± 0.53 15.60 ± 2.31 5.48 ± 1.16 
 
aSteady-state ATPase activity in the absence of actin measured with the NADH coupled assay. 
bMaximum rate of actin-activated ATPase measured with the NADH coupled assay.  The values 
for KATPase and kcat were determined from the fit of the data in Figure 2 to the equation: (V0 + (kcat 
[actin]) / (KATPase + [actin])). 
cActin concentration at which the actin-activated ATPase rate is one-half maximal from the 
NADH assay. 
dActin concentration at which the myosin bound to actin in the actin cosedimentation assay is 
one-half of the total myosin in the assay. 
 
 
Table 1.  Steady-state parameters:  MIIIA K50R vs. MIIIA wt untreated and after 60 min 
incubation with or without ATP. The kinase-inactivating mutation alters the KATPase but 
does not affect V0 or kcat for the steady-state ATPase cycle as compared to untreated wild 
type. Prior phosphorylation as described in Materials and Methods resulted in reduced 
kcat, increased Vo, and increased KActin for MIIIa 2IQ wt, while incubation in the absence 
of ATP (dephos) did not appreciably alter steady state parameters from the untreated 
values.  
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APPENDIX A 
A.1  Autophosphorylation is Slow and [ATP] Dependent 
 One of our earliest tasks was to ascertain the rate of autophosphorylation at a 
constant myosin IIIa concentration and to establish useful experimental conditions for 
autophosphorylation treatments in future assays. We treated MIIIa 2IQ (0.5 µM) at room 
temperature with ATP in the concentration range of 50 µM to 2000 µM and quenched the 
reaction with SDS sample buffer at ten time points within 0 – 60 min of incubation.  
Samples were subjected to SDS-PAGE and Western blotting using ant phosphothreonine 
and antiphosphoserine primary antibodies (Zymed Laboratories Inc), horseradish 
peroxidase-linked IgG secondary antibody (Cell Signaling Technology), and Lumiglo 
chemiluminescence reagent (Cell Signaling Technology).  Densitometry analysis using 
Image J software (NIH) was performed to determine relative band intensities. Membranes 
were stripped and reprobed with anti-FLAG antibody to detect total protein. 
 We found that threonine phosphorylation rates were linearly dependent on ATP 
concentration in the range of 50 to 1000 µM and that autophosphorylation was quite low 
compared to the motor ATPase rate. While many Pak1 kinases turn over rapidly, the s ow 
steady-state rate of the myosin IIIa kinase activity indicated that it does not turn over 
rapidly without phosphorylating the substrate (Wu et al 2003, Dosé et al 2006). We used 
these data to select an ATP concentration of 200 µM and a treatment ti  of one hour for 
further experiments, an ATP concentration at which the threonine phosphorylation rate 
for 0.5 µM MIIIa 2IQ was ~0.2 min-1 (Dosé et al 2006).  (Appendix figure A2). 
 
 68 
A.2  Two Residues Are Autophosphorylated Per Myosin Molecule 
 Time courses were performed to determine the number of target residues that 
become autophosphorylated, following the protocol described in A.1 but using (γ-32P) 
ATP as the substrate.  The number of moles of 32P incorporated per mole of MIIIa 2IQ 
was determined by scintillation counting.  Samples were subjected to SDS-PAGE, bands 
were excised and dissolved in 30% H2O2, and scintillation counting was conducted in 
conjunction with a standard curve.  By comparison to the standard curve it was 
determined that two moles of phosphate were incorporated per mole of myosin, 
indicating that two phosphorylation sites are targeted during the assay (Dosé et al 2006). 
However, because we are only measuring an increase in phosphorylation it is possible 
that an initial level of phosphorylation is present following the exprssion and 
purification process (Dosé et al 2006).  (Appendix figure A3).  In this assay measuring 
total autophosphorylation (both serine and threonine target residues), the rate was 
approximately 2-fold slower than that determined by Western blotting for 
phosphothreonine incorporation.  This indicates that serine phosphorylation is likely and 
that it most likely occurs at a slower rate than threonine phosphorylati n. (Dosé et al 
2006). 
A.3 MIIIA 2IQ ∆Kinase is Not Phosphorylated 
  
 We demonstrated both by Western blotting and by phosphorimaging that the 
kinase-deleted myosin IIIa construct cannot become phosphorylated in the presence of 
ATP during the kinase assay conducted as described above (Appendix Figures A4 A and 
B).  (Dosé et al 2008).  
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A.4 Serine Autophosphorylation is Slower Than Threonine 
Serine phosphorylation proved difficult to interpret due to problems in optimizing 
experimental conditions for the antiphosphoserine antibody.  Our few clear W stern blot 
results suggest that serine phosphorylation does increase during the kinas assay and 
some amount of serine phosphorylation may take place during the cell culture or protein 
preparation, but this line of investigation was redirected in favor of future identification 
of specific target residues.  (Figure A5). 
A.5 Glycine and Lysine Mutants 
 
 
 Prior to development of the K50R mutant, we attempted to inactivate he myosin 
IIIa kinase by creating an individual glycine to alanine point mu ation at each of the three 
glycine residues (G34, G36, and G39) in the highly conserved glycine-ri h loop of the 
kinase’s catalytic region.  This glycine triad is one of the most highly conserved regions 
in kinases, and contributes to the kinase’s nucleotide affinity (Hemmer et al 1997). A 
review of the literature reveals that comparable point mutations in other protein kinases 
have had mixed results (Hemmer et al 1997, Hirai et al 2000, Ikenoue et al 2004). None 
of our mutations successfully inactivated the myosin IIIa kinase, lthough one (G39A) 
appeared to reduce the autophosphorylation rate as compared to wild type. While the 
K50W mutation appeared to abolish autophosphorylation, the construct consistently 
exhibited a very high initial level of phosphorylation that may have included motor 
phosphorylation, which may have contributed to its observed reduced motor ATPase 
activity (Appendix Figure A6).  
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A.6 Dephosphorylation of MIII 2IQ WT 
Because our phosphorylation Western blotss suggested that the MIIIa 2IQ wt construct is 
already phosphorylated at a low level following protein isolation and purification prior to 
experimentation, we attempted to completely dephosphorylate it by phosphata e 
treatment, using calf intestinal phosphatase (CIP) and protein phosphata e 1 (PP1).  
While these treatments did remove the low levels of initial phosphorylati n as detected 
by Western blotting with antiphosphoserine and antiphosphothreonine primary antibodies 
(Appendix Figure A7), the dephosphorylated protein was not detectibly different from 
untreated wild type in the actin-activated ATPase assay (data not shown).  It is likely that 
this was due to rapid rephosphorylation to initial levels once ATP was added to the assay, 
which may involve primarily kinase rather than motor phosphorylation.  
A.7 K50R Transient Kinetics 
 We have partially characterized the transient kinetics of the MIIIa 2IQ K50R 
ATPase, particularly focusing on those components of the ATPase cycl that may 
specifically be altered by the K50R kinase mutation, and those identified as points of 
difference between wild-type and kinase-deleted MIIIa 2IQ in our previous investigations 
(Dosé et al 2008).  
 The rates of ATP binding to the kinase domain and to the motor domain were 
found to be comparable in our K50R construct to those determined in our earlier 
characterization of MIIIa 2IQ wt (Dosé et al 2006) (Appendix Figure A8). Our previous 
characterization of MIIIa 2IQ ∆K had found it to exhibit slow, rate-limiting ATP 
hydrolysis and an accelerated transition between actomyosin.ADP states (Dosé et al 
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2008). However, the data we have collected thus far regarding any differences in rates of 
ATP hydrolysis between MIIIa 2IQ K50R and the wild type construct have been 
inconclusive (Appendix Figure A9). Our results indicate that the transition between the 
two actomyosin.ADP states is rate limiting for the K50R mutant, as it is for wild type, but 
the equilibrium constant governing the transition may be enhanced for K50R.  (Appendix 
Figure A10).   See Appendix Table A1 for values obtained. 
A.8 Autophosphorylation Target Residues 
 An important issue we have attempted to address and remains an ongoi g project 
in our lab is the identification of specific phosphorylation target residues in human 
myosin IIIa.  As noted in A.2, two sites become autophosphorylated during incubation in 
the presence of ATP (Komaba et al 2003, Dosé et al 2007), and it is possible that some 
phosphorylation takes place during the Sf-9 cell culturing process or during protein 
isolation and purification.  Preliminary mass spectroscopy analysis has been conducted 
on our myosin samples by Dr. Stanley Stevens (University of Florida Protein Core 
Facility), pointing to several putative autophosphorylatable sites on both the motor and 
the kinase that warrant further investigation (See Appendix Figure A11).   
 Currently we have several lines of evidence that strongly indicate kinase 
phosphorylation at a threonine corresponding to a phosphorylatable serine/threonine at 
the canonical Pak kinase activation site on the activation loop of its catalytic domain, 
Thr184 in the myosin IIIa kinase domain.  Not only did the mass spectrometry analysis 
indicate phosphorylation at this residue, but the literature indicates that phosphorylation 
at this site is virtually a universal requirement for activation of the Pak kinases (Thr 423 
in mammalian Pak1), which may be accomplished by either intermolecular 
 72 
autophosphorylation or by the activity of another cellular kinase (Lei et al 2000, Lei et al 
2005 review).  Close correlation between the PSSM-determined “most favored” nearby 
residues for Pak1 kinase target specificity and the specific sequence of basic residues 
upstream of T184 (P -5 to P -1) as well the nearby downstream sequenc  also provides 
strong evidence for its in vivo phosphorylation (Rennefahrt e al 2007). We have cloned 
and infected Sf-9 cells with both T184A and T184E MIIIa 2IQ genes, and will soon 
begin investigations to evaluate the significance of phosphorylation at this site. It is 
possible that other kinase domain residues also may be targeted for phosphorylation, 
either for inhibition or for modulation of kinase activity. 
 The motor’s loop 2 residue(s) targeted for autophosphorylation by the human 
myosin IIIa kinase does/do not appear to correspond to either of the autophosphorylation 
targets published for Limulus myosin IIIa (Cardasis et al 2007).  Only one of the sites is a 
serine/threonine in human myosin IIIa, and a serine → alanine substitution did not reduce 
autophosphorylation as detected by antiphosphoserine Western blotting (See Figure 
A12). Indeed, an alignment of fish, human, Drosophila and Limulus myosin III protein 
sequences shows loop 2 to be relatively variable in both length and specific residues, 
especially when comparing vertebrate to invertebrate isoforms (Dosé et al 2003).  
Because the loop’s specific charge characteristics contribute to the motor’s actin affinity 
in certain steps of the ATPase cycle (Yengo and Sweeney 2005) variabilities at loop 2 
may contribute to differences noted between the invertebrate and vertebrate myosin III 
motors.  
 Our preliminary mass spectroscopy analysis suggested threonine-886, upstream 
from the Limulus target residues, as a potential site for autophosphorylation, and 
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comparison with the PSSM-derived predicted surrounding residues provides reasonable 
support to continue with direct testing.  Further verification by mass spectroscopy along 
with direct testing will be required to ascertain these and other potential targets and 
evaluate the functional effects of their autophosphorylation. 
 An additional site on the kinase is also highly likely to be a phosphorylati n 
target, but could not be distinguished between serine-177 and threonine-178.  This site is 
not a consensus target for Pak phosphorylation and may serve to modulate or inhibit 
kinase activity. Because we suspect that there is at least one serine targeted for 
phosphorylation we predict that serine-177 is more likely to be the phosphorylated target 
residue.  However an additional mass spectroscopy analysis will be undertaken to clarify 
these findings. 
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Appendix Figure A1 (Supplemental). Kinase-inactivated myosin IIIa localizes to 
stereocilia tips more effectively than wild-type. (From Kachar Lab, NIH). Mouse inner 
ear hair cells were transfected with human MIIIa full length-GFP construct , the wild 
type (upper left), kinase deleted (lower left), and kinase inactivated (upper and lower 
right).  All of the myosin constructs localized to stereocilia tips, but with variability in 
concentration levels.  Myosin concentrations at the tips were lowest for wild type, high st 
for kinase deleted, and intermediate for kinase inactivated, which provides support for 
our in vitro results using the shortened (MIIIa 2IQ) myosin IIIa constructs. MIIIa is 
visualized with green fluorescent protein, while actin is red (rhodamine-phalloidin 
staining). 
 
 
MIIIa Full wt 
MIIIa Full∆K 
MIIIa Full K50R 
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Figure A2.  Rate of MIIIa 2IQ autophosphorylation was monitored by Western blotting 
with anti-phosphothreonine primary antibody. MIIIa 2IQ (5 µM) was incubated with ATP 
for 0-60 min (room temperature) and the reaction was quenched with SDS loading buffer. 
Increase in phosphothreonine as a function of time was analyzed using Image J software. 
A. Autophosphorylation time course at 565 µM ATP is shown. Data are fit to a single 
exponential function (kobs = 0.46 ± 0.07 min
–1 and linear phase = 0.67 ± 0.05 min–1). Inset 
shows the Western blotting results (minutes of ATP incubation given). B, Initial linear 
phase of the time course allowed us to determine the autophosphorylation rate at each 
ATP concentration. The plot demonstrates that autophosphorylation rate (min–1) is 
linearly dependent on ATP concentration in the concentration range measured (linear fit 
= 0.0010 ± 0.0001 µM–1·min–1). (Dosé et al 2006). 
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Figure A3.  A time course measuring kinase activity was conducted as described earlier, 
using [ -32P]ATP (200 µM) to determine the total amount of phosphate incorporation at 
each time point. Samples were subjected to SDS-PAGE electrophoresis, bands were cut 
out and dissolved in 30% H2O2.  The amount of 
32P incorporation as a function of time 
was fit to a single exponential function (kobs = 0.082 ± 0.02 min
–1, linear phase = 0.16 ± 
0.03 min–1) to determine the maximum number of moles of 32P per mol of myosin III (2.2 
± 0.2). (Dosé et al 2006). 
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Figure A4.  Western blot and phosphorimage of purified MIIIa and MIIIa ∆K 
autophosphorylation. (A) Anti-phosphothreonine Western blot. A time course of MIIIa 
autophosphorylation upon treatment with ATP demonstrates the increase in 
phosphothreonine content over a 60 min period (time points = 0, 1, 5, 30, and 60 min). 
MIIIa ∆K was also examined in the presence of ATP for the same time points as MIIIa. 
The blot was stripped and reprobed with anti-FLAG to assess equal loading of samples. 
(B) Phosphorimage of 32P incorporation by MIIIa 2IQ and MIIIa 2IQ ∆Kinase (60 minute 
room temperature incubation).  No phosphate incorporation was noted for the kinase 
deleted construct within the time of the experiment (Dosé et al 2008).  
A. 
       B. 
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Figure A5.  Western blotting indicates that autophosphorylation targets serine residue(s) 
as well as threonine (see Figure A2).  Autophosphorylation assays were conducted as 
described (200 µM ATP, room temperature), using antiphosphoserine as the primary 
antibody.  Results suggest that autophosphorylation targets for the MIIIa 2IQ kinase
include both serine and threonine residues. The stripping conditions for the time course 
assay appear to not have been completely successful.
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Figure A6.  A. Individual point mutations in the conserved glycine loop of the MIIIa 2IQ 
kinase domain did not abolish autophosphorylation capability as determined by time 
course kinase assays (0-60m incubation with 200 µM ATP at room temperature, 
quenched by SDS sample buffer). B. Both K50R and K50W point mutations appeared to 
abolish autophosphorylation, but were accompanied by high phosphorylation from the 
cell culture/purification process.  The very high initial phosphorylation of K50W was 
associated with low ATPase activity, and so may have involved motor as well as kinase 
phosphorylation. (See further K50R analysis in the main body of this dissertation.)  All 
samples were resolved by SDS-PAGE electrophoresis followed by Western blotting, 
using antiphosphothreonine as the primary antibody.  Stripped membranes were reprobed 
with anti-FLAG antibody to assess evenness of loading. 
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Figure A7.  Treatment with calf intestinal phosphatase for 0 to 60 minutes resulted in 
removal of initial phosphorylation, while incubation with ATP (as described for othe
kinase assays) produced a progressive increase in phosphorylation comparable to other 
similar assays. Dephosphorylated myosin IIIa 2IQ, however, did not give evid nce of 
differences from untreated myosin in steady-state actin-activated ATPase assays (data not 
included).   
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Figure A8. The rate of ATP binding for MIIIa 2IQ K50R was measured by kinetic 
competition with mantATP. MIII 2IQ (K50R) (1 µM) or acto-MIII 2IQ (K50R) was 
mixed with 5 µM mantATP and varying concentrations of ATP.   The rate of the 
fluorescence increase was linearly dependent on ATP concentration in the presence and 
absence of actin. A fast and a slow phase were observed both in the presence and the 
absence of actin, which was interpreted as the difference between rates of ATP binding to 
the kinase vs. the motor domains (Dosé et al, 2006).  A) The fast phase, corresponding to 
kinase binding, was fit to a single exponential function at all ATP concentrations  in the
absence and presence of actin.   B) The slow phase, corresponding to motor binding, was 
fit to a single exponential function at all ATP concentrations in the absence and presence 
of actin. The rate of ATP binding was plotted as a function of ATP concentration to 
determine the equilibrium constant (K1) and maximum rate of ATP binding (k+2). 
B. 
A. 
K1k+2 = 0.0078 ± 0.002 µM
-1
⋅ sec-1 
K1’k+2’ = 0.028 ± 0.005 µM
-1
⋅ sec-1 
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Figure A9.  The MIIIa 2IQ K50R equilibrium constant for ATP hydrolysis determined by 
acid quench experiments.  MIIIa 2IQ K50R (1.0 µM) was mixed with [γ-32P]-ATP 
(100µM) and allowed to age for specific time points (1-20 seconds) before manually 
quenching the reaction with acid. The amount of 32P and thus the amount of ATP 
hydrolyzed was determined by scintillation counting. The data was fit to a single 
exponential function (kobs = 0.22 sec
-1) with a steady state rate (0.01 sec-1) and a burst of 
0.97 µM Pi per µM MIIIa 2IQ K50R.  The maximum rate of ATP hydrolysis was 
determined by kinetic simulation (k+3 + k-3 ≥ 1.0 sec
-1).  Further experimentation is 
required before a conclusive comparison may be made between ATP hydrolysis rate  for 
this construct and MIIIa 2IQ wild type.  
K3 = 10 ± 1 
kobs = 0.22 sec
-1 
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Figure A10.  The rate of mantADP release following binding to actin in the M.ADP.Pi 
state. MIIIa 2IQ K50R (1 µM) (2.25 µM) was mixed with 12.5 µM mantATP, aged for 4 
seconds and then mixed with 20 µM actin and 0.5 mM ADP (final reaction conditions: 
0.5 or 1.13 µM MIIIa 2IQ, 6.25 µM mantATP, 20 µM actin, and 0.5 mM ADP). The 
mant fluorescence transients were fit to a two exponential function for MIIIa 2IQ (K50R) 
representing ADP release from the kinase and motor domains.  Results are contrasted 
with those previously obtained for MIIIa 2IQ ∆K (ADP release from the motor domain 
only), which fit to a single exponential function (Dosé et al 2008). 
 
K50R “kinase”= 36.0 ±1.76 sec-1 
K50R “motor” =  1.6 ± 0.1 sec-1 
 
(∆K “motor” = 9.0 ± 0.2 sec-1) 
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Figure 11.  Mass spectroscopy reports mapping potential phosphorylation target residues 
in myosin IIIa.  Each of the above reports maps one of the three putative 
phosphorylatable residues identified in myosin IIIa samples submitted for analysis. These 
sites were mapped to S177/T178, T184 and T886 respectively. (Dr. Stanley Stevens, 
University of Florida Core Protein Facility).  
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Figure A12.  The point mutation S911A in loop 2 of the human myosin IIIa motor did not 
block serine autophosphorylation.  The band intensity difference between 0 and 60 
minutes was similar for S911A construct and wild type. 
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Table A1.  Summary of rate and equilibrium constants in the myosin IIIA motor ATPase 
cycle. 
ATP Binding and Hydrolysis 
Rate/Equilibrium 
Constant 
MIII  MIII ∆K MIII K50R              
(y-int) 
  aK1k+2 (µM
-1
⋅sec-1) 0.010 ± 0.004 0.031 ± 0.005 0.0078 ± 0.002    
(0.28+0.02)  
bK1k+2 (µM
-1
⋅sec-1) 0.002 ± 0.001 0.075 ± 0.005 N/A 
cK3  9 1.5  
aK’ 1k’ +2(µM
-1
⋅sec-1) 0.005 ± 0.002 0.116 ± 0.013 0.028 ± 0.005      
(0.39±0.05) 
bK’ 1k’ +2 (µM
-1
⋅sec-1) 0.043 ± 0.010 0.099 ± 0.005 N/A 
dK’ 1k’ +2 (µM
-1
⋅sec-1) 0.022 ± 0.001 0.054 ± 0.005 0.066 ± 0.01 
d1/K’ 1 (µM) 11,144 ± 2,319 4,591 ± 1,063 5,016 ± 697 
dk’ +2(sec
-1) 246 ± 38 248 ± 34 269 ± 19 
ADP Binding 
ek’ +5B (sec
-1) 6.8 ± 0.2 6.5 ± 0.1 4.69 ± 0.8 light scatter 
ek’ -5B(µM
-1
⋅sec-1) 1.0 ± 0.1 0.4 ± 0.1 0.2 
eK’ 5B (µM) 6.8 ± 0.4 16.4 ± 2.2 23.6 ± 5.9 
e*k’ +5A (sec
-1) 0.60 ± 0.10 0.67 ± 0.20 0.81 ± 0.18 light 
scatter 
f*k’ +5A (sec
-1) 0.97 ± 0.03 0.62 ± 0.07 0.58 ± 0.023 
f*k’ -5A (sec
-1) 0.54 ± 0.08 0.50 ± 0.10 0.15 ± 0.07 
f*K’ 5A 1.8 ± 0.3 1.2 ± 0.3 3.86 
fk’ +5B (sec
-1) 9.84 ± 0.25 8.5 ± 0.4 6.1 ± 0.3 
fk’ -5B (µM
-1
⋅sec-1) 0.29 ± 0.11 0.29 ± 0.07 0.55 ± 0.49 
fK’ 5B(µM) 34 ± 14 29.1 ± 7.3 11.09 
fk+5A (sec
-1) 1.00 ± 0.24 0.45 ± 0.09 0.05 ± 0.063 
fk-5A (sec
-1) 0.88 ± 0.11 0.35 ± 0.10 0.89 ± 0.06 
fK5A 1.1 ± 0.3 1.2 ± 0.4 0.73 
fk+5B (sec
-1) 9.26 ± 1.55 4.8 ± 1.3 10.11 ± 0.89 
fk-5B (µM
-1
⋅sec-1)  0.31 ± 0.09 0.51 ± 0.12  0.14 ± 0.06                              
fK5B (µM) 30 ± 11 9.4 ± 3.4 71.42 
Actin Binding 
hk+6 (µM
-1
⋅sec-1) 11.4 ± 0.4 21.2 ± 0.4 10.4 ± 1.22 
hk-6 (sec
-1) 1.5 ± 0.1 0.40 ± 0.02                            55 ± 4 
h1/K6 (µM) 0.13 ± 0.01 0.020 ± 0.001  
hk+10A (µM
-1
⋅sec-1) 14.6 ± 0.6 16.8 ± 0.4 Dominated by slow 
phase 
hk-10A (sec
-1) 1.2 ± 0.1 0.30 ± 0.01  
h1/K10B (µM)
 0.08 ± 0.01 0.020 ± 0.001  
hk+10A (µM
-1
⋅sec-1) NA 1.1 ± 0.1 0.13 ± 0.010      0.08 ± 
0.033 
hk-10A (sec
-1) NA 1.1 ± 0.1  
h1/K10A (µM) NA 1.0 ± 0.1  
i1/K10A (µM) 5.0    
Note:  see next page for legend. 
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a mantATP fluorescence 
b ATP binding by competition with mantATP 
c Acid quench with [32P]ATP 
d ATP-induced dissociation monitored by light scatter 
e ADP competition with ATP-induced dissociation monitored by light scatter or pyrene actin 
f mantADP fluorescence 
gPhosphate binding protein 
hPyrene actin fluorescence 
iPredicted from kinetic simulation 
*Note the rate and equilibrium constants defining K’ 5A were modeled with an off-pathway 
intermediate in MIII ∆K. 
 
